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ABSTRACT OF THE DISSERTATION
Neurogenetics of the Externalizing Spectrum
by
Caitlin E Carey
Doctor of Philosophy in Psychological and Brain Sciences
Washington University in St. Louis, 2017
Professor Ryan Bogdan, PhD, Chair
Externalizing spectrum disorders, which include attention-deficit/hyperactivity disorder,
oppositional defiant disorder, conduct disorder, alcohol and substance use disorders, and antisocial
personality disorder, are characterized by behavioral disinhibition and are thought to be
manifestations of a common heritable liability factor throughout the lifespan. However, relatively
little is known about their underlying etiology. Here, I probe genetic and neural risk mechanisms
for externalizing psychopathology in three complementary studies. First, I report an indirect
association between genetic risk for childhood attention-deficit/hyperactivity disorder (ADHD)
and problem drinking in young adulthood, mediated by heightened reward-related neural activity
within the ventral striatum, among 404 college students. I then provide additional support that such
neural activity is a pre-existing risk factor for drinking behaviors by demonstrating that it
prospectively predicts early versus late age-at-first-drink among 65 adolescents. Taken together,
the results of these studies suggest that heightened reward-related ventral striatum activity is a
genetically influenced neural risk marker for the initial stages of drinking behavior and is also
related to ADHD genetic risk. Finally, I performed a genome-wide association study (GWAS) of
retrospectively reported conduct disorder among 1675 Australian adults enriched for externalizing
psychopathology, yielding novel genetic associations with rs12536973 at the single-variant level
ix

and GOLM1 at the gene level. In the sample of college students used in the first study, both
rs12536973 genotype and genome-wide genetic risk calculated based on the results of the GWAS
were associated with self-reported psychopathy constructs, and genome-wide genetic risk was
additionally associated with blunted anterior insula activity during an emotional face-matching
task. Overall, these findings identify potential neurogenetic mechanisms and risk markers for
externalizing psychopathology and provide support for etiological relationships across disorders
(e.g., ADHD and AUD/drinking behaviors), as well as between pathological and non-pathological
externalizing variation (e.g., CD and individual differences in psychopathology among healthy
college students).

x

Chapter 1:
General Introduction
1.1 The Externalizing Spectrum
Externalizing spectrum disorders (ESDs) are characterized by extreme behavioral disinhibition
and include attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD),
conduct disorder (CD), alcohol and substance use disorders (AUD and SUD), and antisocial
personality disorder (ASPD; see Beauchaine & McNulty, 2013, and Beauchaine, Zisner, & Sauder,
2017, for reviews). Lifetime prevalence estimates for ESDs range from 4% for ASPD (Goldstein
et al., 2017) to 29% for AUD (Grant et al., 2015), making them relatively common in the
population. Moreover, given the nature of ESDs, in which, as their name implies, psychopathology
is externalized, their societal consequences reach far beyond the individual level. For example, the
United States spends an estimated 3.3% of its annual gross domestic product on the consequences
of violent crime (Waters et al., 2004), for which ESDs such as CD (Erskine et al., 2016),
AUD/SUD (Arseneault, Moffitt, Caspi, Taylor, & Silva, 2000), and ASPD (Yu, Geddes, & Fazel,
2012) are robust independent predictors.
Despite the substantial personal and societal costs of these disorders, few widely utilized,
cost-effective, empirically supported treatments exist (Cohen, Feinn, Arias, & Kranzler, 2007;
Farmer, Compton, Burns, & Robertson, 2002; Wilson, 2014). With the exception of ADHD and
ODD—notably, both early-childhood-onset disorders—the majority of individuals meeting
criteria for ESDs forego treatment altogether (Cohen et al., 2007; Goldstein et al., 2017;
Merikangas et al., 2011; Wang et al., 2005). Furthermore, in spite of the high degree of homotypic
comorbidity (i.e., co-occurrence of disorders in the same individual) and heterotypic continuity
1

(i.e., sequential diagnosis of different disorders throughout the lifespan) across the externalizing
spectrum, most treatments remain disorder-specific (e.g., psychostimulants for ADHD but
behavioral interventions for CD; Farmer et al., 2002) and thus fail to adequately address the
common underlying externalizing liability (see Section 1.1.1; Beauchaine & McNulty, 2013;
Beauchaine & Hinshaw, 2015). A better understanding of risk factors for continued impairment,
as well as of the biological mechanisms underlying such risk, is thus paramount to developing and
disseminating effective treatment and prevention strategies and reducing the personal and societal
costs associated with externalizing psychopathology (Beauchaine, Neuhaus, Brenner, & GatzkeKopp, 2008).

1.1.1 Structure
As mentioned above, ESDs exhibit a high degree of comorbidity (e.g., 30-50% of children with
ADHD also meet criteria for CD; Biederman, Newcorn, & Sprich, 1991) as well as continuity
(e.g., children diagnosed with ADHD are greater than 2.5-times as likely as nondiagnosed peers
to meet criteria for an SUD in adulthood; Lee, Humphreys, Flory, Liu, & Glass, 2011) and are
therefore thought to be driven by a common underlying liability with different manifestations
across the lifespan (Figure 1.1; Beauchaine & McNulty, 2013; Forbes, Tackett, Markon, &
Krueger, 2016). An adult with ASPD, for example, will have likely transitioned from ADHD in
childhood, to ODD in grade school, to CD in middle school, to AUD and/or SUD in high school,
and finally to ASPD in adulthood (Beauchaine & McNulty, 2013; Moffitt, 1993; Storebo &
Simonsen, 2016).

2

Figure 1.1 Structure and Developmental Trajectory of Externalizing Spectrum Disorders. Latent structure of
the externalizing spectrum, with individual psychiatric disorders loading on a single continuous factor. Arrow indicate
the developmental trajectory of the externalizing spectrum disorders, beginning with ADHD in childhood and
culminating with ASPD in adulthood. Figure adapted from (Beauchaine & McNulty, 2013).

Notably, only a small minority of children with ADHD transition to ASPD in adulthood (Storebø
& Simonsen, 2016), and independent risk factors are thought to play a role in disorder-specific
outcomes (i.e., callous-unemotional traits in CD and ASPD, Frick & White, 2008; availability of
certain drugs in substance-specific SUDs, Kendler et al., 2012, Kendler, Myers, & Prescott, 2007,
and Kendler, Prescott, Myers, & Neale, 2003). Nonetheless, family studies (Hicks, Krueger,
Iacono, McGue, & Patrick, 2004; Krueger et al., 2002; Young, Stallings, Corley, Krauter, &
Hewitt, 2000) and latent factor analyses (Krueger, Markon, Patrick, Benning, & Kramer, 2007;
Krueger, Markon, Patrick, & Iacono, 2005; Markon & Krueger, 2005) of these disorders, their
symptoms, and related traits (i.e., impulsivity, aggression, and [lack of] empathy) have revealed
such behavior to load on one higher-order heritable, continuous “externalizing” construct (Krueger
& South, 2009). A conceptualization of ESDs as completely independent thus obscures the
common traits and mechanisms underlying lifelong risk.

3

1.1.2 Etiology
Genetics
Despite their high degree of symptomatic similarity and comorbidity/continuity, little is known
about the etiological underpinnings of ESDs. The latent externalizing factor has been shown to be
highly heritable (h2~0.80; Krueger et al., 2002), though few replicable individual genetic risk
variants have been identified to date (see Gizer, Otto, & Ellingson, 2016, for review). Earlier
studies focused primarily on candidate genes in known biological systems (e.g., DRD4, which
codes for a dopamine receptor, in ADHD, Faraone, Doyle, Mick, & Biederman, 2001; ADH1B,
which codes for an enzyme that metabolizes alcohol, in AUD, Li, Zhao, & Gelernter, 2011; and
MAOA, which codes for enzymes involved in the breakdown of key neurotransmitters, in CD,
ASPD, and general aggression, Ficks & Waldman, 2014), with some meta-analytic evidence of
association. More recently, genome-wide association studies (GWAS), in which each available
variant in the genome is tested for association with the outcome phenotype, have dominated the
psychiatric and behavioral genetics literatures, with significant loci having been identified for
multiple ESDs (e.g., Table 1.1) and broader transdiagnostic constructs (e.g., behavioral
disinhibition, Derringer et al., 2015; aggressive behavior in childhood, Pappa et al., 2016). Thus
far, GWAS of externalizing psychopathology have both confirmed prior candidate gene
associations (e.g., ADH1B with AUD; Gelernter et al., 2014) and identified promising novel loci
(Table 1.1).
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Table 1.1 Largest Genome-wide Association Study to Date for Each ESD
Disorder
ADHD

Ncases
20,183

Ncontrols
35,191

Significant SNPs
rs11420276, rs1222063, rs9677504, rs4858241,
rs28411770, rs4916723, rs5886709, rs74760947,
rs11591402, rs1427829, rs281324, rs212178

Citation
Demontis et al., 2017

ODDa

-

-

-

-

CD

872

3091b

rs16891867, rs7950811, rs11838918, rs1861046

Dick et al., 2011

AUD/SUDc
ASPD

7677
543

7102
9616

rs1437396, rs1229984d
rs4714329

Gelernter et al., 2014
Rautiainen et al., 2016

a

No case-control GWAS of ODD have been performed to date, but see (Aebi et al., 2016) for a multivariate GWAS
of ODD subtypes.
b
Primary analyses were performed using DSM-IV CD symptom counts.
c
Selected study is of DSM-IV alcohol dependence.
d
SNPs significant in the transethnic meta-analysis. See paper for additional results in ethnic subsamples.

Due to the dimensional nature of the externalizing spectrum, spanning both normal
variation in behavior and personality as well as extreme deviations, the underlying genetic
architecture is posited to be highly polygenic in nature, composed of thousands of individual
variants each of small effect (Gizer et al., 2016; Plomin, Haworth, & Davis, 2009). In the largest
GWAS meta-analysis of ADHD to date , for example, the risk allele at the top locus was associated
with only 1.11 increased odds of developing ADHD (Demontis et al., 2017). As such, single
common variants are unlikely to be clinically useful at the individual level for predicting future
diagnoses, though some notable exceptions exist (e.g., ALDH2 genotype and risk for AUD in East
Asian populations; Luczak, Glatt, & Wall, 2006). Nonetheless, GWAS, when combined with
methodological advances in bioinformatics and statistical genetics, can provide valuable insights
into disorder etiology through functional annotation of top hits (e.g., Schizophrenia Working
Group of the Psychiatric Genomics Consortium, 2014), estimation of genome-wide genetic
correlations between putatively related disorders/phenotypes (e.g., Anttila et al., 2016), and
prediction of potential intermediate phenotypes in independent samples based on genome-wide
genetic risk calculated from summary statistics (e.g., Holmes et al., 2012).
5

Neural Structure and Function
At the neural level, externalizing psychopathology is likely the result of dysfunction across
multiple systems (Table 1.1). Studies of ESDs have typically categorized brain regions and
paradigms into those influencing “hot” and “cool” executive functions and social-emotional
processing (Alegria, Radua, & Rubia, 2016). “Hot” executive functions are goal-directed processes
with motivational and affective significance, such as reward- and punishment-based decisionmaking and reinforcement learning, which are subserved by paralimbic regions of the brain
including the orbitofrontal cortex, anterior cingulate, amygdala, parahippocampal gyrus, insula,
and ventral striatum (Alegria et al., 2016; Kiehl, 2006; Rubia, 2011). “Cool” executive functions,
in contrast, lack an affective component and include processes such as attention, inhibition, and
working memory, which are controlled primarily by circuits linking the frontal, parietal, and
temporal cortices to the dorsal striatum and cerebellum (Rubia, 2011). Social-emotional
processing, sometimes considered in tandem with “hot” executive functions due to regional and
paradigmatic overlap (Rubia, 2011), includes functions such as empathy, theory-of-mind, and
emotion processing, which are associated with paralimbic regions of the brain such as the
amygdala, insula, anterior cingulate, orbitofrontal cortex, and temporal lobe (Lindquist, Wager,
Kober, Bliss-Moreau, & Barrett, 2012; Ochsner, 2008; Raschle, Menks, Fehlbaum, Tshomba, &
Stadler, 2015).

6

Table 1.2 Prior Reviews/Meta-analyses of Externalizing Spectrum Neuroimaging Studies
Citation
Alegria et al., 2016

Phenotype(s)
DBDs
(CD
and
ODD)
and conduct
problems

Modality
functional

Paradigms
“hot” and “cool” EF,
emotion processing,
and empathic pain

Nstudies
24

Main Findingsa
↓ activity in the rostral and dorsal anterior cingulate,
medial prefrontal cortex, and ventral striatum

Cortese et al., 2012

ADHD

functional

all available

55

↓ activity across the frontal, parietal, and temporal lobes,
as well as in the putamen; ↑ activity in the angular gyrus,
middle occipital gyrus, posterior cingulate, middle
cingulate, Heschl’s gyrus, and inferior frontal gyrus

McCarthy et al., 2014

ADHD

functional

“cool” EF

20

↓ frontal lobe activity relative to controls

Noordermeer et al., 2016

ODD and CD,
w/ and w/o
comorbid
ADHD

structural &
functional

“hot” and “cool” EF

structural: 12
functional: 17

↓ grey matter volume and activity (driven primarily by
that of “hot” executive functioning tasks) in the
amygdala, striatum, insula, frontal gyrus, and precuneus

Plichta & Scheres, 2014

ADHD, trait
impulsivity

functionalb

reward processing

ADHD: 10
healthy: 12

↓ ventral striatum activation, particularly during reward
anticipation, among ADHD vs. controls; ↑ ventral
striatum activation among healthy individuals scoring
higher on trait impulsivity

Raschle et al., 2015

aggressive
behavior

structural &
functional

emotion processing
and empathy

structural: 8
functional: 9

↓ grey matter volume and activity in the dorsomedial
prefrontal cortex and insula

Rogers et al., 2016

conduct
problems

structural

-

13

↓ grey matter volume in the insula, amygdala, medial
superior frontal gyrus, and fusiform gyrus

Yang et al., 2016

AUD

structural

-

12

↓ grey matter volume in the insula, superior temporal
gyrus, striatum, dorsolateral prefrontal cortex, precentral
gyrus, anterior cingulate, thalamus, and hippocampus

a

Findings are reported from the broadest analysis in each study (e.g., analyses across structural and functional data, or all task types).
Study considered activation within a ventral striatum region of interest only.
Note. Highlighted studies should be considered representative but not exhaustive. DBD = disruptive behavior disorder. EF = executive functions.
b
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When comparing neural activity across disorders and constructs comprising the
externalizing spectrum, as would be expected when studying syndromes that load on both firstorder disorder-specific factors and a higher-order common externalizing factor (Beauchaine &
McNulty, 2013), both similarities (e.g., Alegria et al., 2016; Frodl, 2010) and disorder-specific
differences (e.g., Plichta & Scheres, 2014; Rubia, 2011) have been noted. For example, differences
in reward-related activity within the ventral striatum, a region critical to generating and
orchestrating motivated behavior including reward sensitivity and reinforcement learning
(Berridge & Kringelbach, 2015), have been independently associated with ADHD (Plichta &
Scheres, 2014), disruptive behavior disorders (DBDs; i.e., CD and ODD; Alegria et al., 2016;
Noordermeer et al., 2016), AUD/SUD (Balodis & Potenza, 2015; Hommer, Bjork, & Gilman,
2011), drinking patterns (Weiland, Zucker, Zubieta, & Heitzeg, 2016), and trait impulsivity
(Kennis, Rademaker, & Geuze, 2013), though directionality of association has been mixed and is
the subject of some controversy (e.g., see Balodis & Potenza, 2015; Hommer et al., 2011; Plichta
& Scheres, 2014, 2015). In contrast, highlighting potential disorder-specific associations, though
ADHD and DBDs frequently co-occur, comparisons have revealed differences in “cool” executive
function regions to be somewhat specific to ADHD, while dysfunctions of “hot” executive
function and emotion processing regions are unique to DBDs (Alegria et al., 2016; Rubia, 2011).
This finding would suggest that youths with comorbid ADHD and DBD have an “extra”
neurobiological impairment relative to those with ADHD alone, placing them at increased risk for
long-term negative outcomes such as substance (mis)use (Brook, Brook, Zhang, & Koppel, 2010;
Wilens et al., 2011).
Notably, one major limitation of prior cross-sectional case-control imaging studies is that
it has not been possible to disentangle premorbid risk factors from downstream effects of disorder
8

expression and related confounds (e.g., medication). This is a particularly salient issue in studies
of AUD and SUD, wherein long-term use of substances is thought to alter brain structure and
function (e.g., Filbey et al., 2014; Squeglia, Jacobus, & Tapert, 2014). Two complementary
approaches—genetic/familial high-risk and longitudinal studies—may be useful in distinguishing
[putative] cause from effect. For example, using a discordant twins/siblings design, Pagliaccio and
colleagues (2015) demonstrated that decreased amygdala volume among cannabis users is likely
a genetically influenced preexisting risk factor for cannabis use, rather than a consequence of use.
Longitudinal studies have likewise shown that heightened reward-related activity in the striatum
prospectively predicts the onset of substance use (Heitzeg et al., 2014; Stice, Yokum, & Burger,
2013). Using such techniques, the transdiagnostic and specific biological risk factors for ESDs
may be elucidated, providing neurobiological targets for treatment and prevention strategies to halt
the progression of externalizing sequelae across the lifespan.

1.2 Current Aims
The current collection of studies aims to identify neurogenetic mechanisms underlying various
forms of externalizing behavior (i.e., ADHD in Chapter 2, drinking behavior in Chapters 2 and
3, and CD and psychopathy in Chapter 4) using archival data from three complementary,
independent datasets covering different developmental periods (i.e., early-to-late adolescence,
young adulthood, and middle adulthood). Building on prior literature, these studies focus
specifically on identifying premorbid genetically influenced neurobiological risk factors, rather
than downstream consequences of disorder expression.
In Chapter 2, based on epidemiological observations of enhanced risk for future alcohol
and substance use disorders among children diagnosed with ADHD (Charach, Yeung, Climans, &
9

Lillie, 2011; S. S. Lee et al., 2011), and family studies demonstrating such externalizing continuity
to be due primarily to heritable genetic factors (Derks, Vink, Willemsen, van den Brink, &
Boomsma, 2014; Quinn et al., 2015), I tested whether a putative transdiagnostic neural phenotype,
reward-related blood oxygen level-dependent functional magnetic resonance imaging (BOLD
fMRI) activity within the ventral striatum, links genetic risk for childhood ADHD to problematic
alcohol use in young adulthood among 404 college students. Such an association would be
consistent with developmental models of the externalizing spectrum, which posit that shared
genetic and neurobiological risk manifest as different ESDs across the lifespan (Beauchaine &
McNulty, 2013; M. K. Forbes et al., 2016).
In Chapter 3, using the same fMRI reward paradigm as in Chapter 2, I investigated
whether reward-related neural activity within the ventral striatum prospectively predicts alcohol
use initiation, indexed by relative age-of-first-drink, in a longitudinal neuroimaging study of 65
adolescents, consistent with (Heitzeg et al., 2014; Stice et al., 2013). Given the substantial
continuity between ADHD and problematic alcohol use (Charach et al., 2011; S. S. Lee et al.,
2011), convergence in the results of Chapters 2 and 3 would suggest a common genetically
influenced neural mechanism underlying both disorders.
Finally, in Chapter 4, I performed a GWAS of retrospectively reported CD among 1675
adult participants enriched for externalizing psychopathology. Based on the results of the GWAS,
I tested whether genetic risk for CD (i.e., significant GWAS loci and genome-wide genetic risk
scores based on summary statistics) was also associated with self-reported psychopathy and neural
activity to a social-emotional processing task in the college sample from Chapter 2, consistent
with literature suggesting emotion processing to be uniquely impaired in DBDs such as CD and
adult antisocial behavior and psychopathy (Alegria et al., 2016; Rubia, 2011). Identification of
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genetic and genetically influenced neural risk factors related to both CD diagnosis and normal
variability in trait psychopathy within a healthy young adult population would provide evidence
for a spectrum of externalizing risk, particularly as it relates to antisocial behavior and
psychopathy, with common genetic and neurobiological influences.
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Chapter 2:
Neurogenetic Underpinnings of Childhood
ADHD and Problematic Alcohol Use
Continuity
2.1 Introduction
Attention-deficit/hyperactivity disorder (ADHD) is characterized by persistent hyperactivityimpulsivity and/or inattention, and is among the most common childhood psychiatric disorders,
affecting approximately 5% of children worldwide (Polanczyk, de Lima, Horta, Biederman, &
Rohde, 2007). In addition to deficits in cognitive (Willcutt, Doyle, Nigg, Faraone, & Pennington,
2005), academic (Barry, Lyman, & Klinger, 2002), and socioemotional (Strine et al., 2006)
domains during childhood, evidence suggests a continued pattern of impairment extending to
adolescence and adulthood (Shaw et al., 2012). Problematic alcohol use, typically conceptualized
as levels of use associated with significant socioemotional, academic, or workplace impairment,
is especially prevalent among these individuals, with prospective studies demonstrating that
children with ADHD are at substantially increased (e.g., 1.35-1.72) odds of developing alcohol
use disorder (AUD) as adults (Charach et al., 2011; Lee et al., 2011). Supportive of a common
etiology (Carragher et al., 2014), twin studies have shown that shared additive genetic factors
primarily account for this association (e.g., 91-99.8% of phenotypic covariance; Derks et al., 2014;
Quinn et al., 2015). However, what neural mechanisms, if any, may mediate the effects of this
shared genetic liability remain largely unexplored. Identifying such mechanisms is important not
only for better understanding the etiology of ADHD but also for informing the development of
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novel strategies for preventing comorbid dysfunction by providing target intermediate neural
phenotypes that can serve as risk biomarkers.
Differences in neural response to reward may be one way through which shared genetic
risk for ADHD and problematic alcohol use manifests. For example, emotional and motivational
facets of impulsivity (i.e., positive and negative urgency) prospectively mediate the association
between childhood ADHD and adult problematic alcohol use (Pedersen et al., 2016). At the neural
level, ADHD (Plichta & Scheres, 2014; von Rhein, Cools, Zwiers, et al., 2015), trait impulsivity
(Hariri et al., 2006; Plichta & Scheres, 2014), and problematic alcohol use (Balodis & Potenza,
2015; Hommer et al., 2011) have each been associated with variability in reward-related brain
function, particularly within the ventral striatum (VS; Berridge & Kringelbach, 2015). Moreover,
a recent study identified transcripts associated with impulsive behavior within a mouse model and
then showed that variation in the sequence of the genes coding for these transcripts in humans was
associated with impulsivity, VS reactivity to reward, and problematic alcohol use during
adolescence (Peña-Oliver et al., 2016). Collectively, this evidence suggests that genetically
influenced individual differences in reward-related brain function may contribute to shared risk
between childhood ADHD and later problematic alcohol use.
Though prior studies of comorbidity and continuity have relied upon twin and family
designs enriched for clinical cases (Derks et al., 2014; Knopik et al., 2006; Quinn et al., 2015),
recent advances in statistical genetics allow for quantitation of genetic risk in healthy individuals
without knowledge of family history. Building on the idea that psychiatric disorders represent
extremes of continuous phenotypes normally distributed throughout the population (Plomin et al.,
2009), it follows that those with a greater number of common risk variants for a particular disorder
will be at heightened risk for diagnosis. Indices of genome-wide genetic risk, commonly referred
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to as polygenic risk scores (PRS; Purcell et al., 2009), can be calculated based on the number of
disorder risk alleles an individual possesses. The increasing availability of genome-wide
association study (GWAS) summary statistics, made possible through collaborative efforts such
as the Psychiatric Genomics Consortium (PGC; http://www.med.unc.edu/pgc/), has facilitated the
exploration of mechanisms of genetic risk for psychiatric disorders in independent non-clinical
samples (Belsky et al., 2016; Hagenaars et al., 2016; Krapohl et al., 2015), which typically benefit
from larger sample sizes and are generally without the confounds of clinical symptom expression
and medication.
In the current study, I investigated whether alterations in reward-related VS activity
mediated links between polygenic risk for childhood ADHD and problematic alcohol use among
404 non-Hispanic Caucasian young adults. VS activity to reward was measured using blood
oxygen level-dependent functional magnetic resonance imaging (BOLD fMRI), and defined as
relative activity to positive versus negative feedback associated with monetary reward (CorralFrias et al., 2015). ADHD PRS were calculated based on a PGC meta-analysis of childhood ADHD
(Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013). Based on existing
literature (Balodis & Potenza, 2015; Hariri et al., 2006; Hommer et al., 2011; Peña-Oliver et al.,
2016; Plichta & Scheres, 2014; von Rhein, Cools, Zwiers, et al., 2015), I hypothesized that both
polygenic risk for childhood ADHD and self-reported problematic alcohol use would be associated
with individual differences in reward-related VS activity, and that variability in VS activity would
mediate the association between polygenic risk and problematic alcohol use during young
adulthood.
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2.2 Methods
2.2.1 Participants
Self-report, neuroimaging, and genomic data were available from 438 non-Hispanic Caucasian 18to 22-year-old undergraduate students who completed the ongoing Duke Neurogenetics Study
(DNS; Corral-Frias et al., 2015) by April 4, 2015. Ancestry was determined by self-report and
confirmed genetically (see Section 2.2.3). Participants provided informed written consent prior to
the DNS protocol, which was approved by the Duke University Medical Center Institutional
Review Board. Study exclusion criteria were as follows: 1) medical diagnosis of cancer, stroke,
diabetes requiring insulin treatment, chronic kidney or liver disease, or, importantly, lifetime
psychotic symptoms; 2) use of psychotropic, glucocorticoid, or hypolipidemic medication; and 3)
conditions affecting cerebral blood flow and metabolism (e.g., hypertension). DSM-IV Axis I and
select Axis II (i.e., borderline and antisocial personality) disorders were assessed with the
electronic Mini International Neuropsychiatric Interview (Sheehan et al., 1998) and Structured
Clinical Interview for the DSM-IV Axis II (First, Gibbon, Spitzer, Williams, & Benjamin, 1997).
Participants were excluded for the following quality control issues: a large number of
movement or signal intensity outliers in fMRI data (n=24), an inadequate behavioral feedback
schedule (n=2), scanner/equipment malfunction (n=3), subjects falling asleep (n=1), incidental
structural findings (n=1), and relatedness (n=2, removed randomly from related pairs of
participants). Following these exclusions, a final sample of 404 participants (Mage=19.79±1.25;
213 females) remained.
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2.2.2 Measures
Problematic alcohol use was assessed using the 10-item Alcohol Use Disorders Identification Test
(AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993), which was designed to assess
past-year hazardous (e.g., “How often do you have six or more drinks on one occasion?”),
dependent (e.g., “How often during the last year have you found that you were not able to stop
drinking once you had started?”), and harmful (e.g., “Have you or someone else been injured
because of your drinking?”) patterns of alcohol consumption in primary-care settings. Given that
the AUDIT is useful only for assessing problem use among drinkers, nondrinkers (i.e., those who
reported not having drank alcohol in the past 12 months, n=50) were excluded from analyses
involving this measure, leaving 354 drinkers for analysis. Consistent with prior studies in college
students (e.g., Kokotailo et al., 2004), the AUDIT demonstrated acceptable psychometric
properties in in this sample (α=0.818; MAUDIT=6.59±4.20; Figure 2.1) but were log-transformed
prior to analyses to reduce positive skew.

Figure 2.1 Raw Distribution of AUDIT Scores Among Past-year Drinkers. Scores of 8 and above, out of a
maximum possible 40, are considered indicative of problem drinking (Saunders et al., 1993).
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2.2.3 Genetics
Genotyping
DNA was isolated from saliva derived from Oragene DNA self-collection kits (DNA Genotek)
customized for 23andMe (www.23andme.com). DNA extraction and genotyping were performed
by the National Genetics Institute (NGI), a CLIA-certified clinical laboratory and subsidiary of
Laboratory Corporation of America. One of two different Illumina arrays with additional custom
content, the HumanOmniExpress or HumanOmniExpress-24 (Hu et al., 2016), was used to provide
genome-wide single nucleotide polymorphism (SNP) data. Genotype imputation was run
separately for participants typed on each array using the pre-phasing/imputation stepwise approach
implemented in SHAPEIT (Delaneau, Marchini, & Zagury, 2012) and IMPUTE2 (Howie,
Fuchsberger, Stephens, Marchini, & Abecasis, 2012) using only biallelic SNPs and the default
value for effective size of the population (20,000), and chunk sizes of 3Mb and 5Mb for the
respective arrays. Within each array batch, genotyped SNPs used for imputation were required to
have missingness <0.02, Hardy-Weinberg equilibrium (HWE) p-values >10-6, and minor allele
frequency (MAF) >0.01. The imputation reference set consisted of 2,504 phased haplotypes from
the full 1000 Genomes Project Phase 3 dataset (May 2013, over 70 million variants, release “v5a”).
Imputed SNPs were retained if they had high imputation quality (INFO >0.9), low missingness
(<5%), and MAF >0.01.
Relatedness was assessed using pairwise identity by descent estimation in PLINK (v.1.07;
Purcell et al., 2007). Population stratification reflecting genetic heterogeneity associated with
ancestry was assessed using identity by state analysis of whole-genome SNPs. The top 10
multidimensional scaling (MDS) components of this analysis were used to confirm self-reported
ancestry (i.e., that no individuals were outliers of greater than ±6SD on any component). The top
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2 components were then selected based on visual inspection of the scree plot for use as covariates
in all analyses to account for occult population stratification.
Polygenic Risk Scores
Polygenic risk scores were derived from GWAS summary statistics for the ADHD subset of the
PGC’s cross-disorder meta-analysis, which included 1947 trio cases, 1947 trio pseudocontrols,
840 cases, and 688 controls (http://www.med.unc.edu/pgc/results-and-downloads; Cross-Disorder
Group of the Psychiatric Genomics Consortium, 2013). Because the original meta-analysis did not
assess predictive utility of PRS in additional case-control samples and thus did not identify an ideal
threshold for the inclusion of variants, PRS were constructed for p-value thresholds 0.0001, 0.001,
0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 1.0, to be consistent with the PRS analyses conducted in the
PGC cross-disorder paper. SNPs were required to have MAF >0.02, genotyping rates >0.98, and
HWE p-values >10−6. SNPs within the major histocompatibility complex (MHC) region (chr6:
25000000:35000000) were excluded due to their complex patterns of linkage disequilibrium. All
remaining SNPs were pruned using p-value-informed clumping (i.e., grouping linked SNPs;
R2=0.10, 500kb window). For each P-value threshold, using the --score method in PLINK (v.1.07;
Purcell et al., 2007), the log odds-ratio for ADHD for each component SNP (i.e., those in the
original meta-analysis with p-values below the cutoff threshold) was multiplied by the number of
reference alleles for that SNP before being summed and divided by the total number of contributing
SNPs to produce a single metric for each participant representing cumulative genome-wide risk
for childhood ADHD. To assess the specificity of ADHD polygenic risk relative to risk for
neurodevelopmental disorders more generally, PRS were generated for autism spectrum disorders
(ASD) in the same manner based on summary statistics from a meta-analysis conducted by the
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http://www.med.unc.edu/pgc/results-and-downloads; Robinson et al., 2016).

2.2.4 Neuroimaging
Corticostriatal Reactivity Paradigm
A number-guessing paradigm (Figure 2.2; Corral-Frias et al., 2015; Delgado, Nystrom, Fissell,
Noll, & Fiez, 2000), consisting of a pseudorandom presentation of three blocks each of
predominantly positive (80% correct guess) or negative (20% correct guess) feedback, interleaved
with three control blocks, was used to probe VS activity associated with positive and negative
feedback linked to monetary gains and losses.

Figure 2.2 BOLD fMRI Corticostriatal Reactivity Paradigm. Paradigm consisted of a pseudorandom presentation
of 3 blocks each of predominantly positive (80% correct guess) or negative (20% correct guess) fixed feedback,
interleaved with 3 control blocks. During each trial, depicted here, participants saw the back of a card and were given
3000ms to guess whether the card was greater or less than 5 (face cards excluded). After a choice was made, the value
of the card was displayed for 500ms, followed by appropriate feedback for 500ms and then a crosshair for 3000ms.

During each trial, participants saw the back of a card and were given 3000ms to guess whether the
card was greater or less than five, face cards excluded. After a choice was made, the value of the
card was displayed for 500ms, followed by appropriate feedback for 500ms and then a crosshair
for 3000ms. Correct versus incorrect feedback was indicated by a green upward-facing arrow or a
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red downward-facing arrow, respectively. In the control condition, participants saw an X for
3000ms, during which they were instructed to push a button, which was followed by an asterisk
for 500ms and then a yellow circle for 500ms. Participants were unaware of the fixed outcome
probabilities associated with each block and led to believe that their performance would determine
their monetary gain at the end of the scanning sessions. However, all participants received $10 in
winnings regardless of performance.
Acquisition
Participants were scanned using one of two identical research-dedicated GE MR750 3T scanners
equipped with high-power high-duty-cycle 50-mT/m gradients at 200 T/m/s slew rate, and an
eight-channel head coil for parallel imaging at high bandwidth up to 1MHz at the Duke-UNC Brain
Imaging and Analysis Center. A semi-automated high-order shimming program was used to ensure
global field homogeneity. A series of 34 interleaved axial functional slices aligned with the anterior
commissure-posterior commissure (AC-PC) plane were acquired for full-brain coverage using an
inverse-spiral pulse sequence to reduce susceptibility artifact (TR/TE/flip angle=2000 ms/30
ms/60; FOV=240 mm; 3.75×3.75×4 mm voxels [selected to provide whole brain coverage while
maintaining adequate signal-to-noise and optimizing acquisition times]; interslice skip=0). Four
initial RF excitations were performed (and discarded) to achieve steady-state equilibrium. To
allow for spatial registration of each participant’s data to a standard coordinate system, highresolution three-dimensional structural images were acquired in 34 axial slices co-planar with the
functional scans (TR/TE/flip angle=7.7 s/3.0 ms/12; voxel size=0.9×0.9×4 mm; FOV=240 mm,
interslice skip=0).
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(SPM8;

http://www.fil.ion.ucl.ac.uk/spm) was used for whole-brain image analysis. Individual subject data
were first realigned to the first volume in the time series to correct for head motion before being
spatially normalized into the standard stereotactic space of the Montreal Neurological Institute
(MNI) template using a 12-parameter affine model. Next, data were smoothed to minimize noise
and residual differences in individual anatomy with a 6mm full width at half maximum (FWHM)
Gaussian filter. Voxel-wise signal intensities were ratio normalized to the whole-brain global
mean. Then the ARTifact Detection Tool (ART; http://www.nitrc.org/projects/artifact_detect/)
was used to generate regressors accounting for image outliers due to large motion (i.e., >0.6mm
relative to the previous time frame) or spikes (i.e., global mean intensity 2.5 standard deviations
from the entire time series). Participants for whom more than 5% of acquisition volumes were
flagged by ART were removed from analyses. A 5mm sphere based on the maximum voxels from
a prior study (Hariri et al., 2006) was used to ensure adequate ventral striatum coverage; no
participant had <90% coverage of the region.
Analysis
Following preprocessing steps, the general linear model in SPM8, employing canonical
hemodynamic response functions, was used to estimate condition-specific (i.e., positive feedback,
negative feedback, and control block) BOLD responses for each individual. Consistent with prior
studies (Corral-Frias et al., 2015; Hariri et al., 2006; Nikolova, Knodt, Radtke, & Hariri, 2016), I
focused on activity resulting from the contrast of all positive feedback blocks relative to negative
feedback blocks (Positive Feedback > Negative Feedback) as an index of neural activity associated
with monetary gains versus losses. As outlined in SPM8’s random-effects analysis via summary
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statistics approach (Holmes & Friston, 1998; Penny, Holmes, & Friston, 2003), Positive Feedback
> Negative Feedback contrast images (i.e., weighted sums of single-condition beta images) for
each individual were used in a second-level random effects model to determine mean contrastspecific responses using a one-sample t-test.
Left and right VS regions of interest (ROIs) were defined using a 10mm sphere based on
the maximum voxels from a prior study (Hariri et al., 2006). A voxel-level statistical threshold of
p<0.05, family-wise error (FWE) corrected for multiple comparisons across the ROIs, and a
cluster-level extent threshold of 10 contiguous voxels, were applied to these analyses. In-line with
prior work (Corral-Frias et al., 2015) and recent recommendations (Tong et al., 2016), parameter
estimates from functional clusters within these ROIs were extracted, which were then used for all
statistical analyses. To maintain variability but constrain the influence of extreme outliers, prior to
analyses all imaging variables were winsorized (i.e., following data quality control procedures,
outliers more than M±3SDs [n=5 for left VS, n=3 for right VS] were set at ±3SDs from the mean).

2.2.5 Statistical Analyses
Sex and the top two ancestry-informative multidimensional scaling components (Purcell et al.,
2007) were entered as covariates for all analyses to control for possible confounding effects of sex
and occult population stratification. For analyses involving alcohol phenotypes, being of legal
drinking age in the US (i.e., at least 21) was also included as a covariate of no interest (nlegal=132,
nunderage=222).
Ordinary least squares regression was used to test the association between each thresholded
ADHD PRS and left and right VS activity, as well as direct associations with AUDIT scores. To
address multiple testing, I implemented a label-swapping permutation procedure to assess whether
the overall pattern of association across thresholds differed from that expected by chance. In each
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of 10,000 permutations, an individual’s genetic data (i.e., PRS at all thresholds and ancestryinformative MDS components) were swapped but dependent variables (i.e., left and right VS
activity to reward, AUDIT scores) and non-genetic covariates (i.e., sex and, when appropriate,
being of legal drinking age) were left intact in order to generate a null distribution. For each
permutation, the number of nominally significant (i.e., p<0.05) associations were summed.
Empirical significance of the overall association pattern, PPRS, was calculated as the number of
permutations for which the number of nominally significant associations equaled or exceeded that
reported in our analyses, divided by the number of permutations performed (i.e., 10,000). I adopted
this approach due to the nested structure of PRS scores across p-value thresholds (i.e., each
threshold contains all SNPs in more stringent p-value thresholds).
To examine links from genes to brain to behavior, a mediational model was tested in MPlus
(v.7.11; Muthén & Muthén, 2012) with ADHD PRS as the predictor, VS activity as the mediating
variable, and AUDIT scores as the dependent variable. Because such a model is dependent upon
associations between ADHD PRS and VS activity, I conducted these analyses at the p-value
threshold most strongly associated with VS activity (i.e., P<0.30). Full information maximum
likelihood estimation was used, and unstandardized indirect effects were computed for each of
5000 bootstrapped samples, consistent with the recommendations of (Hayes, 2009).

2.3 Results
2.3.1 Main Effects
Consistent with prior work, the contrast of interest (i.e., Positive Feedback > Negative Feedback)
yielded robust bilateral VS activity (Figure 2.3A). ADHD PRS were significantly associated with
bilateral VS activity (Left VS: significant at 6 of 10 P-value thresholds; largest effect at P<0.30:
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β=0.132, ΔR2=0.017, p=0.008; Right VS: significant at 6 of 10 P-value thresholds; largest effect
at P<0.30: β=0.124, ΔR2=0.015, p=0.013; Figure 2.3B).

Figure 2.3 Main Effects of fMRI Task and ADHD Polygenic Risk on Reward-Related Activity in the Ventral
Striatum. A) Bilateral ventral striatal (VS) reactivity to reward (Positive Feedback > Negative Feedback) across all
participants. Right hemisphere: Montreal Neurological Institute (MNI) coordinates = 12, 10, and -8 (t=13.287, p< 0.05
FWE), cluster size = 239 voxels. Left hemisphere: MNI coordinates = -12, 8, and -8 (t=14.394, p<0.05 FWE), cluster
size = 293 voxels. B) ADHD polygenic risk scores (PRS) and bilateral ventral striatal reactivity to reward. Y-axis is
the percent of variation in VS reactivity explained by ADHD PRS. Positive values indicate a positive association
between ADHD PRS and VS reactivity. Negative values are for display purposes only and indicate a negative
association between ADHD PRS and VS reactivity. Shades of gray in legend indicate the P-value threshold at which
the risk score was calculated.
* p < .05. ** p < .01. *** p < .001.

Permutation analyses revealed that the overall bilateral pattern of associations across thresholds
significantly deviated from that expected by chance (PPRS=0.013). The negative control, ASD PRS,
was not associated with VS activity at any threshold (all ps>0.15). ADHD PRS failed to predict
problematic alcohol use across thresholds (significant only at P<0.01: β=0.103, ΔR2=0.010,
p=0.050; PPRS=0.223). However, bilateral VS activity was significantly associated with
problematic alcohol use (Left VS: β=0.172, ΔR2=0.029, p<0.001; Right VS: β=0.149, ΔR2=0.022,
p=0.004). Repetition of analyses with raw (i.e., non-winsorized, untransformed) data did not alter
results.
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2.3.2 Structural Equation Model
Due to the consistency in results across hemispheres, a combined bilateral ROI was used for
structural equation modelling. Within the full model (Figure 2.4A), polygenic risk scores
positively predicted VS activity (βPRS=0.132, 95% CI [0.025, 0.244], p=0.019; Figure 2.4B),
which, in turn, positively predicted problematic alcohol use (βVS=0.162, 95% CI [0.068, 0.259],
p<0.001; Figure 2.4C). The indirect pathway from ADHD PRS to problematic alcohol use through
VS activity was significant (βIND=0.021, 95% CI [0.005, 0.051], p<0.01).

2.3.3 Supplemental Follow-up Alcohol Use Initiation Analysis
To provide preliminary evidence that heightened VS activity to reward likely preceded the
emergence of problematic drinking, as implied by the setup of my structural equation model, I
analyzed whether bilateral VS activity predicted the future initiation of alcohol use among baseline
nondrinkers (n=50). After successful completion of the baseline protocol including fMRI,
participants were subsequently contacted by e-mail every 3 months and invited to complete a short
online assessment which included the AUDIT. Follow-up analyses were performed using data
from the most recent timepoint (n=29; M days since baseline completion=609.71±390.80, range:
91-1615). Of these individuals, 15 reported drinking at follow-up. Logistic regression analyses
with sex, two ancestry-informative MDS components, whether one was of legal drinking age (i.e.,
21+) at follow-up, and days since baseline assessment as covariates of no interest demonstrated
that heightened bilateral VS activity to reward at baseline was predictive of drinking initiation at
follow-up (β=3.735, Nagelkerke ΔR2=0.276, p=0.021).
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Figure 2.4 Structural Equation Model Demonstrating the Effect of ADHD Polygenic Risk on Problematic
Alcohol Use through Bilateral Ventral Striatum Activity to Reward. The overall model is depicted in A, with raw
data plots of the significant a and b pathways shown in B and C, respectively. The dashed line in A represents the
indirect effect of ADHD PRS on problematic alcohol use through bilateral ventral striatum activity to reward. Sex and
the top two ancestrally-informative MDS components were included as covariates of no interest for all paths in the
full model. Being of legal drinking age in the US (i.e., age 21+) was included as a covariate in paths involving alcohol
use outcomes (i.e., b and c’).
* p < .05. ** p < .01. *** p < .001.
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2.4 Discussion
Twin and family studies have shown that shared genetic factors account for the majority of
phenotypic variance between childhood ADHD and problematic alcohol use during adolescence
and adulthood (Derks et al., 2014; Knopik et al., 2006; Quinn et al., 2015). Here, I have extended
this work by providing initial evidence that polygenic risk for childhood ADHD predicts
heightened reward-related ventral striatum activity, which, in turn, is associated with problematic
alcohol use in young adulthood (Figure 2.4). Alongside evidence that elevated neural responsivity
to reward is found among adolescents with ADHD and their unaffected siblings (von Rhein, Cools,
Zwiers, et al., 2015), and that such reactivity is associated with alcohol use initiation and escalation
(Heitzeg et al., 2014; Weiland et al., 2016), these results suggest that elevated ventral striatum
activity to reward may be a genetically-influenced neural mechanism mediating the link between
polygenic risk for childhood ADHD and later problematic alcohol use.

2.4.1 Childhood ADHD and Later Problematic Alcohol Use
Despite compelling prior epidemiological evidence of associations between childhood ADHD
diagnosis and later problematic alcohol use (Charach et al., 2011; Lee et al., 2011), as well as
previous twin and family studies demonstrating substantial genetic overlap between the two (Derks
et al., 2014; Knopik et al., 2006; Quinn et al., 2015), I observed no direct association between
polygenic risk for childhood ADHD and problematic alcohol use. Of note, though not significant
across p-value thresholds, the directionality of associations was consistent with the
epidemiological literature (i.e., higher childhood ADHD polygenic risk leading to greater reported
problem drinking). While it is possible that an absence of a statistically significant direct
association is an artifact of my likely underpowered sample (i.e., 80% power to detect an R2 of
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0.023, when variance explained by PRS in population-based studies is generally 1% or less; Belsky
et al., 2016; Hagenaars et al., 2016; Krapohl et al., 2015), I have previously reported a similar lack
of association in a larger (N=2573) sample ascertained for substance use disorders, including
alcohol dependence (Carey et al., 2016). It is possible that the association between polygenic risk
for ADHD and problematic alcohol use occurs indirectly through altered neural mechanisms of
reward sensitivity and reinforcement learning and/or that a direct association would require a larger
sample to detect.

2.4.2 ADHD and Associations with Reward-Related VS Activation
Although neural and behavioral research on ADHD has traditionally focused on deficits in
executive functioning (Cortese et al., 2012; McCarthy, Skokauskas, & Frodl, 2014; Willcutt et al.,
2005), more recent theoretical models of the disorder have proposed a key role for dysfunctional
motivation and reward-related processes (Castellanos, Sonuga-Barke, Milham, & Tannock, 2006;
Luman, Tripp, & Scheres, 2010). For example, in healthy adults, individual differences in VS
activity during both reward anticipation and outcome are positively associated with behavioral and
self-reported indices of impulsivity and reward responsiveness (Forbes et al., 2009; Hariri et al.,
2006; Plichta & Scheres, 2014). ADHD symptoms and diagnosis, in contrast, have been
predominantly characterized by lower VS responsiveness to reward-predicting cues (see Plichta &
Scheres, 2014, for meta-analysis and review, but see also von Rhein, Cools, Zwiers, et al., 2015,
and subsequent commentary in Plichta & Scheres, 2015, and von Rhein, Cools, Mennes, &
Buitelaar, 2015). Neural activation to reward outcome has been less systematically studied in
ADHD, with some evidence of relative hyper-responsiveness (Furukawa et al., 2014; von Rhein,
Cools, Zwiers, et al., 2015; Paloyelis, Mehta, Faraone, Asherson, & Kuntsi, 2012; but see also
Scheres, Milham, Knutson, & Castellanos, 2007, and Wilbertz et al., 2012). This discrepancy in
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relative VS activation to reward anticipation versus outcome may reflect impaired reward learning
(Furukawa et al., 2014), consistent with evidence of impaired behavioral modification based on
prior reinforcement history in ADHD (Tripp & Alsop, 1999). Given the design of the
corticostriatal reactivity paradigm in the DNS, in which mean VS activation was compared across
positive versus negative feedback blocks (with non-valence-specific cues), my results may more
appropriately reflect emergent data linking ADHD to increased VS response to reward outcomes
(Furukawa et al., 2014; Paloyelis et al., 2012; von Rhein, Cools, Zwiers, et al., 2015). Notably, the
current findings of elevated VS activity to positive versus negative feedback among young adults
at higher polygenic risk for childhood ADHD complement those of a prior family study (von
Rhein, Cools, Zwiers, et al., 2015) in suggesting that heightened neural responsiveness to reward
may be a heritable neural mechanism through which ADHD expression manifests.

2.4.3 Reward-Related VS Activation and Risk for Problematic Alcohol Use
As with ADHD, addiction has been contextualized as a disorder of altered reward sensitivity and
abnormal reinforcement learning. Influential theories of addiction emphasize the importance of
conceptualizing the disorder within stages, whereby substance use initiation and initial problematic
use are related to the positively reinforcing aspects of a substance, while later compulsive use is
driven by negative reinforcement and diminished cognitive control resulting from chronic useinduced changes in neural plasticity and a revised homeostasis that includes the presence of the
substance (Everitt & Robbins, 2016; Koob, 2013; Koob & Le Moal, 2005; Volkow, Fowler, Wang,
Baler, & Telang, 2009; Wise & Koob, 2014). Heightened VS activity to reward may characterize
the initial stages (i.e., initiation and escalation) of substance use, causing at-risk individuals to be
more likely to engage in initiation and also be more sensitive to the positively reinforcing aspects
of the substance (Hommer et al., 2011). Repeated use of substances, in contrast, may result in
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overstimulation and consequent downregulation of reinforcement mechanisms (Volkow et al.,
2009; Volkow, Fowler, Wang, & Swanson, 2004), thus decreasing VS activity to natural reward
and increasing the threshold required to reach prior levels of responsiveness (Hommer et al., 2011).
Consistent with this model, increased striatum activity to reward in adolescence prospectively
predicts substance use initiation (Stice et al., 2013) and problem drinking (Heitzeg et al., 2014),
and is retrospectively related to age-of-first-drunkenness across both individuals with AUD and
healthy volunteers (Weiland et al., 2016). In contrast, the vast majority of studies among
individuals with AUD have reported decreased VS reactivity to monetary reward cues (Balodis &
Potenza, 2015; Hommer et al., 2011) but hyperresponsive to alcohol cues relative to controls
(Wrase et al., 2007), indicating a shift in reward responsiveness from more generally salient stimuli
(e.g., money) to the conditioned substance of choice as the disorder progresses.
My results, showing that elevated VS activation during reward processing indirectly links
polygenic risk for ADHD to problematic alcohol use among young adult college students, are
therefore consistent with a heightened reward sensitivity model of substance use
initiation/escalation conferred by childhood ADHD polygenic risk. Due to my relatively healthy
sample, however, these findings cannot exclude the possibility that childhood ADHD polygenic
risk impacts later stages of substance use disorders (e.g., transition to and maintenance of
dependence) either through the VS or alternative neural pathways (e.g., the cognitive control
circuit: Holmes, Hollinshead, Roffman, Smoller, & Buckner, 2016; Rooney, Chronis-Tuscano, &
Huggins, 2015). Additional studies of genetic risk, in concert with longitudinal studies, are needed
to better elucidate the temporal associations between reward-related VS activity and ADHD and
AUD.
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2.4.4 Limitations
Several limitations are important to consider when interpreting the results of this study. First,
despite being large for a neuroimaging study (N=404), the sample was small for genetic association
analyses, which, as in other imaging genetics studies, may increase the risk of false negative and
false positive findings and result in imprecise effect estimates (Bogdan, Pagliaccio, Baranger, &
Hariri, 2016). Correspondingly, the childhood ADHD GWAS meta-analysis used to generate PRS
in this study is small relative to more recent meta-analytic efforts (e.g., schizophrenia:
Ncase=36,989, Ncontrol=113,075; Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014), and, perhaps due to its resultant lack of power, did not yield any genome-wide
significant loci. As a result, it will be important for this observed association to be replicated and
extended once larger ADHD GWAS meta-analyses and additional neurogenetics samples become
available.
Second, because ADHD diagnosis and symptomatology were not assessed in the DNS, it
is not possible to rule out whether disorder expression is a mediating factor between polygenic risk
and reward-related VS activity. One possible explanation for my results is that higher polygenic
risk leads to ADHD, and that the disorder itself is then associated with increased VS activity to
reward. Correspondingly, I was unable to validate whether childhood ADHD PRS were indeed
predictive of retrospective diagnosis in the current sample. However, a prior population-based
study demonstrated that ADHD PRS derived from the same meta-analysis used for this study was
predictive of childhood, but, intriguingly, not adult, ADHD, thus indicating the utility and,
somewhat surprisingly, childhood specificity of these scores (Moffitt et al., 2015).
Third, the DNS is cross-sectional, making it impossible to establish temporal order for the
association between VS activity and problematic alcohol use. As a result, I cannot rule out that
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alcohol misuse may have preceded increases in VS activity. However, longitudinal studies of the
effect of VS activity on future alcohol use are consistent with our model (Heitzeg et al., 2014).
Furthermore, within our subsample of baseline nondrinkers who also had follow-up AUDIT data
(n=29), VS activity predicted future initiation of drinking, providing some preliminary evidence
for temporality.
Fourth, the functional paradigm used in the DNS (Corral-Frias et al., 2015), due to its
blocked design, does not allow for the examination of distinct components of reward processing.
The current results thus cannot be directly compared to those of prior studies of reward-related VS
activity in ADHD and AUD, which have generally examined reward anticipation and outcome
separately (Balodis & Potenza, 2015; Plichta & Scheres, 2014).
Lastly, the indirect association between polygenic risk and problematic alcohol use is a
small effect that is not currently informative on an individual level. Nonetheless, the effect size is
consistent with those reported in prior studies using PRS (Belsky et al., 2016; Hagenaars et al.,
2016; Krapohl et al., 2015), and these findings identify a promising neural mechanism that
provides etiologic insight into associations between childhood ADHD and problematic alcohol use
and is worthy of future study.

2.4.5 Conclusion
Limitations notwithstanding, the current study provides initial evidence that relatively heightened
reward-related VS activity mediates associations between polygenic risk for childhood ADHD and
problematic alcohol use in young adulthood. Future studies may wish to interrogate dissociations
between reward anticipation and receipt as they relate to genetic risk for ADHD and problematic
alcohol use, and to extend these findings to additional substance use and externalizing disorders.
Furthermore, as imaging and genetics sample sizes increase, pathway enrichment analyses (e.g.,
32

Lee, O'Dushlaine, Thomas, & Purcell, 2012) and functional annotation (e.g., Finucane et al., 2015)
may allow for the discovery of specific molecular pathways that underlie genetic associations
between ADHD, neural reward activity, and problematic alcohol use. Overall, the current findings
suggest that elevated VS response to reward is a promising neural mechanism through which
ADHD polygenic risk and problematic drinking may manifest.
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Chapter 3:
Neural Risk Markers for Adolescent Alcohol
Use Initiation
3.1 Introduction
Alcohol use is a significant public health issue, with approximately 3.3 million deaths worldwide
per year directly attributable to alcohol consumption (World Health Organization, 2014) and
roughly 30% of individuals in the United States meeting criteria for Alcohol Use Disorder (AUD)
during their lifetimes (Grant et al., 2015). Alcohol misuse has been increasingly contextualized
within a developmental framework, with adolescence as a particularly influential period (Chassin,
Sher, Hussong, & Curran, 2013; Zucker, 2015). The typical age-of-first-drink in the US is in early
adolescence (i.e., median age of 14; Chen, Yi, & Faden, 2013), with patterns such as regular use,
binge drinking, and heavy use typically emerging and escalating throughout adolescence, peaking
in the early 20s, and then plateauing or tapering off in adulthood (Johnston, 2016; Substance Abuse
and Mental Health Services Administration, 2015). Individuals with an earlier onset of alcohol use
are at higher risk for problematic drinking patterns, including AUD diagnosis, in later adolescence
and adulthood (Chou & Pickering, 1992; Dawson, Goldstein, Chou, Ruan, & Grant, 2008; DeWit,
Adlaf, Offord, & Ogborne, 2000; Grant & Dawson, 1997; Hingson, Heeren, & Winter, 2006). As
such, it is important to identify biological risk factors associated with early initiation of alcohol
use during adolescence to better understand and perhaps prevent developmental transitions to
problematic use patterns and eventual dependence.
One potential neurobiological mechanism underlying the initiation of alcohol use in
adolescence is the staggered maturation of the brain’s subcortical reward (e.g., ventral striatum
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[VS]) and cortical cognitive control (e.g., prefrontal cortex) systems (see Casey & Jones, 2010, for
review). During adolescence, the subcortical reward system matures first (Galván, 2013), while
the cognitive control system lags behind (Gogtay et al., 2004). This creates a developmental period
of imbalance during which “bottom-up” reward/motivation signals are relied upon to a greater
degree in driving behavior than “top-down” cognitive control signals (Casey & Jones, 2010).
Correspondingly, heightened subcortical activity to reward, particularly within the VS, is thought
to characterize the initial stages of substance use, causing at-risk individuals to be more likely to
initiate use and also be more sensitive to the positively reinforcing aspects of the substance
(Hommer et al., 2011). Increased striatum activity to reward in adolescence, for example,
prospectively predicts substance use initiation (Stice et al., 2013) and problem drinking (Heitzeg
et al., 2014), and is retrospectively related to age-of-first-drunkenness across individuals with
AUD and healthy volunteers (Weiland et al., 2016). Given its implication in alcohol and substance
use and its maturational overlap with a time of increase in both, reward-related activity within the
VS, and the reward system in general, is a strong candidate neural risk mechanism underlying the
timing of alcohol use initiation.
In this study, using archival longitudinal data from 65 baseline alcohol-naïve participants
in the Teen Alcohol Outcomes Study (TAOS; Bogdan, Williamson, & Hariri, 2012), I tested
whether reward-related ventral striatum activity prospectively predicted relatively early (i.e., age
15 or less) vs. late (i.e., age 18 or greater) age-at-first-drink. TAOS participants were scanned in
early adolescence (age range: 12 to 15) while performing a monetarily incentivized numberguessing task, during which blood oxygen level-dependent functional magnetic resonance imaging
(BOLD fMRI) data were acquired (Corral-Frias et al., 2015; Hariri et al., 2006). Self-reported
alcohol use was assessed at a maximum of six timepoints annually, with the initial assessment
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coinciding with the fMRI scan. Based on prior literature (Heitzeg et al., 2014; Stice et al., 2013;
Weiland et al., 2016), as well as the results of Chapter 2, I hypothesized that increased rewardrelated VS activity would be associated with earlier initiation of alcohol use.

3.2 Methods
3.2.1 Participants
Teen Alcohol Outcomes Study (TAOS) participants (N=331), ages 11 to 15 at baseline, were
recruited via phone from the San Antonio, Texas, metro area within a 30-mile radius of University
of Texas Health Science Center at San Antonio (UTHSCA; Bogdan et al., 2012). As TAOS seeks
to investigate factors contributing to risk for psychopathology, participants with a family history
of major depressive disorder (MDD), which is associated with increased risk for MDD, anxiety,
and substance use disorders (Weissman et al., 2006), were over-sampled. Participants provided
assent, with parents providing written informed consent, following procedures approved by the
UTHSCA Institutional Review Board. To be eligible for the study, participants were required to
be medically healthy, free of contraindications to MRI (e.g., braces), and not have a psychiatric or
substance use disorder, aside from anxiety, at baseline, as assessed by the Kiddie Schedule for
Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (KSADS-PL; Kaufman et al., 1997). Reported binge drinking at baseline, as defined by the NIAAA
guidelines (i.e., 4+ drinks on one occasion for females or 5+ drinks on one occasion for males;
National Institute on Alcohol Abuse and Alcoholism), was also grounds for exclusion. After
assenting/consenting, participants completed in-person interviews, self-report behavioral
assessments, and fMRI scanning. Participants were re-contacted annually to complete diagnostic
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interviews and questionnaires, for a maximum of six timepoints (including baseline) to date, and
also underwent a follow-up scanning session approximately two years post-baseline.
For the current analyses, participants who reported having had at least one alcoholic drink
by the time of the baseline assessment (n=9), or for whom baseline drinking status could not be
determined due to missingness or discrepancies in self-report (n=25), were excluded. Additionally,
to ensure adequate assessment of age-at-first-drink, participants were required to have either
initiated drinking during the course of the study (n=98), or to have continued the study to the age
of 18 without having initiated drinking (n=30). Of the remaining participants, 9 did not complete
the corticostriatal reactivity paradigm scan, and an additional 31 were removed for issues of
imaging quality control (i.e., a large number of movement or signal intensity outliers, n=23, or an
inadequate behavioral feedback schedule, n=8; see Section 3.3.2). Following these exclusions,
usable self-report and baseline imaging data were available for 88 participants (Mage =13.59±0.96;
40 females; 61% non-Hispanic Caucasian, 23% Hispanic, 11% Other).

3.2.2 Measures
Age-at-first-drink
At baseline and each annual follow-up session, participants were asked to report their lifetime and
past-year use of 16 types of licit and illicit substances, including alcohol, on a substance use
checklist. For each substance a participant endorsed, they completed the corresponding section of
the Substance Use Questionnaire (SUQ; Molina et al., 2007), which asks questions regarding the
quantity, frequency, and experiences of past-year substance use. Participants who reported having
initiated alcohol use at any timepoint (i.e., “Did you have your very first drink since your last
interview here?”) were subsequently asked at what age they had their first drink (i.e., “How old
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were you the first time you had a drink, not just a sip or a taste?”). This was used as an age-atfirst-drink metric (M=15.50±1.61; Figure 3.1) among alcohol use initiators (n=66).

Figure 3.1 Distribution of Age-at-first-drink Among Initiators.

To incorporate continuous nondrinkers (i.e., participants who reached the age of 18 without
having initiated alcohol use) into analyses and simultaneously maximize power, I assigned
participants to two groups based on early (i.e., age-at-first-drink ≤15; n=34) versus late (i.e., ageat-first-drink ≥18; n=31) initiation of alcohol use (Table 3.1). A third intermediate group (i.e.,
15<age-at-first-drink<18, n=23) was also created but not used in primary analyses. Age cutpoints
were selected based on a desire to maximize group sizes while maintaining at least two years of
distance between “early” and “late” initiators.
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Table 3.1 Age-at-first-drink Subsample Demographics
Variable
N
Age at Baseline
Tanner Stage >III at Baseline
Female
Non-Hispanic Caucasian
Hispanic

Early
34
13.49(0.89)
61.8%
44.1%
79.4%
20.6%

Middle
23
14.01(0.86)
56.5%
47.8%
47.8%
26.1%

Late
31
14.29(0.70)*, 1
83.9%
45.2%
54.8%1
32.3%

*Indicates a significant difference between early and late groups.
1
Indicates a significant difference between early and middle groups.
2
Indicates a significant difference between middle and late groups.

Pubertal Status
Pubertal status was assessed at baseline using the Tanner scales (Marshall & Tanner, 1969, 1970)
and binarized, consistent with a prior TAOS study (Dotterer, Hyde, Swartz, Hariri, & Williamson,
2017), into individuals in Stage III or less, reflecting less pubertal development, and those above
Stage III, reflecting greater development.

3.2.3 Neuroimaging
Corticostriatal Reactivity Paradigm
A monetarily incentivized number-guessing paradigm (Figure 2.2; Corral-Frias et al., 2015;
Delgado et al., 2000), described in detail in Section 2.2.4, was used to elicit reward-related VS
activity.
Acquisition
BOLD fMRI images were acquired on a Siemens 3T Trio scanner using a gradient-echo, echo
planar imaging (EPI) sequence (TR=2000 ms, TE=25 ms, FOV=192 mm, matrix=64x64),
covering 34 interleaved 3 mm-thick axial slices. To allow for spatial registration of each
participant’s data to a standard coordinate system, structural MRI images were acquired with a T1weighted MPRAGE sequence (TR=2200 ms, TE=2.8 ms, slice thickness=0.8 cm, FOV=256 mm).
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Preprocessing
The

general

linear

model

of

Statistical

Parametric

Mapping

8

(SPM8;

http://www.fil.ion.ucl.ac.uk/spm) was used for whole-brain image analysis. Individual subject data
were first realigned to the first volume in the time series to correct for head motion before being
spatially normalized into the standard stereotactic space of the Montreal Neurological Institute
(MNI) template using a 12-parameter affine model. Next, data were smoothed to minimize noise
and residual differences in individual anatomy with a 6mm FWHM Gaussian filter. Voxel-wise
signal intensities were ratio normalized to the whole-brain global mean. Then the ARTifact
Detection Tool (ART; http://www.nitrc.org/projects/artifact_detect/) was used to generate
regressors accounting for image outliers due to motion (i.e., >2 mm or degrees relative to the
previous time frame) or spikes (i.e., global mean intensity >4 standard deviations from the entire
time series). Participants for whom more than 5% of acquisition volumes were flagged by ART
were removed from analyses (n=23). For the remaining participants, ART generated regressors to
control for outlier volumes in analyses. A 5mm sphere based on the maximum voxels from a prior
study (Hariri et al., 2006) was used to ensure adequate (i.e., 90%) ventral striatum coverage
bilaterally; all participants had sufficient coverage of the region.
Analysis
Following preprocessing steps, linear contrasts employing canonical hemodynamic response
functions were used to estimate task-specific BOLD responses to different forms of feedback (i.e.,
positive and negative) for each individual. Consistent with prior studies (Corral-Frias et al., 2015;
Hariri et al., 2006; Nikolova et al., 2016), I focused on activity resulting from the contrast of all
positive feedback blocks relative to negative feedback blocks (Positive Feedback > Negative
Feedback) as an index of neural activity associated with monetary gains versus losses. As outlined
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in SPM8’s random-effects analysis via summary statistics approach (Holmes & Friston, 1998;
Penny et al., 2003), Positive Feedback > Negative Feedback contrast images (i.e., weighted sums
of single-condition beta images) for each individual were used in a second-level random effects
model to determine mean contrast-specific responses using a one-sample t-test.
Left and right VS regions of interest (ROIs) were defined using a 5mm sphere based on the
maximum voxels from a prior study (Hariri et al., 2006). A voxel-level statistical threshold of
p<0.05, family-wise error (FWE) corrected for multiple comparisons across the ROIs, and a
cluster-level extent threshold of 10 contiguous voxels, were applied to these analyses. In-line with
prior work (Corral-Frias et al., 2015) and recent recommendations (Tong et al., 2016), parameter
estimates at the maximum voxels of functional clusters within these ROIs were extracted, which
were then used for all statistical analyses. To maintain variability but constrain the influence of
extreme outliers, prior to analyses all imaging variables were winsorized (i.e., following data
quality control procedures, outliers more than M±3SDs [n=2 for left VS, n=1 for right VS] were
set at ±3SDs from the mean).

3.2.4 Statistical Analyses
To examine reward-related neural predictors of age-at-first-drink, logistic regressions with
membership in the early versus late initiation group as the dependent variable and either left or
right VS activation as the predictor were performed. In addition to these analyses, an exploratory
whole-brain independent samples t-test was conducted in SPM8, employing cluster-level familywise error (FWE) correction as implemented by AFNI’s 3dClustSim (Cox, 1996). A mask was
created by thresholding SPM8’s a priori probabilistic grey matter image at >0.20 to restrict
analyses to grey matter only. Consistent with recent recommendations (Cox, Chen, Glen,
Reynolds, & Taylor, 2017; Cox, Reynolds, & Taylor, 2016), smoothness of the residuals for the
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whole-brain independent samples t-test was first assessed using AFNI’s 3dFWHMx with the -acf
option, which fits the estimated spatial autocorrelation function (ACF) to a Gaussian-plus-monoexponential mixed model. Estimated ACF parameters were then averaged across residuals and fed
into 3dClustSim, which uses 10,000 Monte Carlo simulations to form a null distribution of cluster
sizes (i.e., nominally significant positive voxels touching at either faces or edges; NN=2, one-sided
thresholding, α=0.05) based on a pre-specified cluster-forming threshold. The output of
3dClustSim is the minimum cluster size k at the specified cluster-forming threshold such that α is
controlled. Due to evidence that liberal cluster-forming thresholds (i.e., p<0.05) do not
appropriately control the Type I error rate (Eklund, Nichols, & Knutsson, 2016), a conservative
cluster-forming threshold of p<0.001 was used. Covariates for all analyses included age and
pubertal status at baseline, gender, and race/ethnicity.

3.3 Results
Consistent with prior work, the contrast of interest (i.e., Positive Feedback > Negative Feedback)
yielded robust VS activity, though somewhat left-lateralized (Figure 3.2A). Left, but not right, VS
activity predicted early vs. late initiation of drinking (Left VS: β=0.926, p=0.019; Right VS: β=0.070, p=0.844), such that for every standard-deviation increase in left VS activity, odds of early
vs. late initiation increased by a factor of 2.524 (Figure 3.2B). No significant differences emerged
between the middle group and either of the extreme initiation groups (ps>0.20). Use of a
continuous variable, right-censored at the age of 19, rather than binned age groups, and a linear
model, yielded a nonsignificant trend (β=-0.142, p=0.106), wherein greater left VS activation at
baseline was associated with earlier age-at-first-drink. Exploratory whole-brain analyses of early
vs. late initiators did not reveal any regions surviving family-wise error correction (i.e., k=108 at
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p<0.001 uncorrected); however, it is worth noting that a voxel within a cluster in the left VS was
the most differentially active between the two groups (Figure 3.2C).

Figure 3.2 Reward-related VS Activation and Relationship to Age-at-first-drink. A) Bilateral ventral striatal (VS)
activity to reward (Positive Feedback > Negative Feedback) across all participants. Right hemisphere: max voxel MNI
coordinates=[12, 10, -6], t=3.44, p<0.05 FWE, k=13 voxels. Left hemisphere: max voxel=[-14, 14, -12], t=4.37,
p<0.05 FWE, k=56 voxels. B) Mean reward-related left VS activation for each initiation group. Values are unadjusted.
The middle group (AFD at ages 16-17) is greyed out, as it was not included in initial analyses between early and late
initiators. Error bars reflect standard error of the mean. C) Maximally activated voxel in the whole-brain contrast of
early initiators vs. late initiators. Max voxel=[-12, 4, -14], t=4.03, p<0.001 uncorrected, k=12 voxels.
* p < .05.
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3.3 Discussion
Prior studies have repeatedly linked earlier age-at-first-drink (AFD) to problematic alcohol use
and AUD diagnosis (e.g., Dawson et al., 2008; DeWit et al., 2000; Grant & Dawson, 1997), though
biological risk mechanisms for AFD itself have remained largely unexplored. The results of the
current study provide support for the hypothesized prospective relationship between rewardrelated ventral striatum activation and AFD, wherein greater VS activity to positive versus
negative feedback in a monetarily incentivized BOLD fMRI number-guessing task at baseline
predicted relatively early (i.e., age 15 or younger) versus late (i.e., age 18 or older) AFD. These
findings, considered with those of previous imaging studies of alcohol/substance use initiation
(Heitzeg et al., 2014; Stice et al., 2013), escalation (Weiland et al., 2016), and problem drinking
(Chapter 2), suggest a key role for reward processing in general, and ventral striatum activity in
particular, in the early stages of alcohol use.
As discussed in Chapter 2, pathways to addiction are thought to occur in stages—
including initiation, progression and escalation to regular/heavy use, and finally disordered use
(Heath, Martin, Lynskey, Todorov, & Madden, 2002; Hines, Morley, Mackie, & Lynskey, 2015;
Neale, Harvey, Maes, Sullivan, & Kendler, 2006)—with age-at-first drink thus being the first point
of individual differences in this model. General and specific biological and environmental risk
factors are thought to affect each stage (Hines et al., 2015; Kendler, Myers, Dick, & Prescott, 2010;
Sartor, Lynskey, Heath, Jacob, & True, 2007). AFD, for example, has been associated with
behavioral disinhibition and reward responsiveness, and is therefore thought to be more generally
related to externalizing psychopathology risk that to risk for alcohol use disorder in particular
(McGue, Iacono, Legrand, Malone, & Elkins, 2001; Pardo, Aguilar, Molinuevo, & Torrubia, 2007;
Zernicke, Cantrell, Finn, & Lucas, 2010; but see also Dawson et al., 2008). In contrast, later
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progression to dependence may be moreso influenced by susceptibility to the physiological and
psychological effects of substances (Koob et al., 2004; Schuckit, 1994), thus reflecting SUDspecific risk factors. Correspondingly, rather than acting as an independent causal factor in the
pathway to eventual AUD (Prescott & Kendler, 1999; Ystrom, Kendler, & Reichborn‐Kjennerud,
2014), earlier age-at-first-drink is thought to be reflective of a heritable propensity towards
externalizing behavior (McGue, Iacono, Legrand, & Elkins, 2001; McGue, Iacono, Legrand,
Malone, et al., 2001; Pardo et al., 2007; Zernicke et al., 2010), with evidence of common genetic
factors influencing both AFD and AUD (Sartor et al., 2009; Ystrom et al., 2014). Within this
framework, age-at-first-drink is not only a predictor of future AUD (i.e., 14% decrease in the odds
of dependence for each year of delay in AFD; Grant & Dawson, 1997), but also a behavioral
expression of heritable biological risk.
The current findings provide evidence that increased VS activity during reward processing
is one such biological risk factor influencing AFD and likely the eventual expression of AUD. The
few previous prospective imaging studies of substance use initiation have focused primarily on the
impulsivity-related construct of response inhibition, reporting less activation in cognitive controlrelated regions among future initiators relative to continuous nondrinkers (Mahmood et al., 2013;
Norman et al., 2011; Wetherill, Squeglia, Yang, & Tapert, 2013). Combined with the results of
this study and another which showed increased dorsal striatum (i.e., caudate and putamen) activity
in response to monetary reward among adolescents who initiated substance use within one year of
the initial scan (Stice et al., 2013), this suggests that the neural underpinnings of multiple facets of
impulsivity, including response inhibition and reward sensitivity, may be markers for substance
use initiation. Notably, however, my study was the first to investigate AFD, controlling for age at
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baseline, rather than whether or not an individual initiated within a certain follow-up period (e.g.,
1 year from baseline).
Importantly, these findings have critical implications for the treatment and prevention of
alcohol and substance use disorders. If AFD is indeed an expression of heritable risk related to
neural reward processing and behavioral disinhibition, rather than a causal environmental factor,
then public health efforts to restrict access to alcohol and other substances during adolescence will
not address the underlying liability. Instead, interventions targeting reward processing, general
impulsiveness, and the early and adequate treatment of other forms of externalizing pathology may
be more effective in preventing/delaying initiation and subsequent progression to disordered use.
Future studies with both imaging and genetic or familial data should seek to further establish
whether these behavioral and functional neural risk markers exhibit co-heritability with AFD, and
whether they fully mediate associations between AFD and progression to dependence.

3.3.1 Limitations
The results of the current study should be interpreted in the context of several limitations. First,
AFD as a construct has been the subject of recent controversy (see Kuntsche, Rossow, Engels, &
Kuntsche, 2016b, and subsequent commentary in Alati, 2016; Diemen & Kessler, 2016; Hingson,
Zha, & White, 2016; Kuntsche, Rossow, Engels, & Kuntsche, 2016a; and Windle, 2016), with
some researchers arguing that the transition from first drink to problem drinking is a more robust
predictor of problematic alcohol use and AUD in adulthood (Kuntsche et al., 2013). Most criticism
of AFD has focused on lack of consensus regarding how to operationalize “first drink” (i.e.,
whether to include sips versus full drinks only) as well as lack of evidence for specific causal
influence on later drinking problems (Kuntsche et al., 2016b). Within the current study, first drink,
relative to first sip, was explicitly defined as “a 12-oz. can or a bottle of beer, a 6-oz. glass of wine,
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a 12-oz. wine cooler, a shot glass of hard liquor, or a mixed drink with 1 shot (1 1/2 oz.) of hard
liquor, like whiskey, scotch, vodka, gin, rum, or tequila,” thus providing a more specificity relative
to prior studies in which first sip was included. Additionally, the direct causality of AFD was not
relevant to the current study, as I was investigating neural risk markers for AFD rather than using
it as a predictor for future problems.
Relatedly, AFD was assessed via self-report and thus may not be entirely accurate. For
example, two baseline nondrinkers in the current sample subsequently reported ages-of-first-drink
preceding their baseline scans. I tried to mitigate this issue by assessing age-at-first-drink at the
first timepoint at which a participant ever reported drinking—presumably while his or her first
drink would be fresh in his or her mind mind—and also by binning AFDs into early, middle, and
late initiation groups. It is worth noting that it is possible that some individuals in the late initiator
group may have continued to abstain; however, given that 86.4% of adults report drinking during
their lifetimes (Substance Abuse and Mental Health Services Administration), it is more likely that
they simply delayed initiation. Additionally, my definitions of early (i.e., AFD≤15), middle (i.e.,
15<AFD<18), and late (i.e., AFD≥18) initiation were sample-specific and selected to maximize
cell sizes for the extreme groups contrast. As such, they should not be viewed as reflective of
population-level initiation patterns, which have generally demonstrated the median age-of-firstdrink to be 14 (Chen et al., 2013).
Finally, due to lack of variability in post-initiation drinking behaviors within this sample
(see Appendix A for a more detailed discussion of this issue), I was unable to test for relationships
between reward-related VS activation and later stages of alcohol (mis)use. Future longitudinal
studies, perhaps of longer duration or covering a later developmental period, may wish to
investigate whether reward-related VS activation is also related to escalation of use and/or
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transition to problem drinking—including binge drinking, heavy use, and alcohol use disorder—
above-and-beyond the association with AFD. One might expect, for example, that increased VS
activation would be related to escalation of use and transition to problem drinking, but not with
transition to or maintenance of AUD. Such research would allow for a more thorough interrogation
of the role of neural reward processing, specifically within the VS, in the context of stage models
of addiction.

3.3.2 Conclusions
Despite these limitations, the current findings provide additional evidence that increased rewardrelated VS activity is a neural risk marker for earlier initiation of alcohol use, as indexed by ageat-first-drink. Such an association is consistent with increased reward sensitivity being a key factor
in the initial stages of alcohol, and possibly other-substance, use (Hommer et al., 2011),
particularly during the sensitive developmental period of adolescence (Casey & Jones, 2010). This
study confirms and extends prior studies of the role of reward-related activation within the striatum
in early stages of alcohol use (Heitzeg et al., 2014; Stice et al., 2013; Weiland et al., 2016), as well
as lays the groundwork for future studies of reward-processing in later stages of addiction.
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Chapter 4:
Conduct Disorder Genome-Wide Association
Study and Extension to Social-Emotional
Brain Function
4.1 Introduction
Conduct disorder (CD) is a child and adolescent externalizing disorder characterized by persistent
aggressive, deceitful, and rule-breaking behavior (American Psychiatric Association, 2013) that
affects 2.1% of individuals under the age of 18 worldwide (Polanczyk, Salum, Sugaya, Caye, &
Rohde, 2015). The disorder is associated with a significant global burden of disease (i.e., 5.75
million years lived with disability; Erskine et al., 2014) and substantial public cost (i.e., >$15,000
per diagnosed child per year in the United States; Beecham, 2014; Foster & Jones, 2005). Further,
individuals with CD are at greater risk for other psychiatric disorders (e.g., depression/anxiety:
OR=2.10), substance involvement (e.g., illicit drug use: OR=2.11), academic underachievement
(e.g., failure to complete high school: OR=2.69), risky sexual behaviors (e.g., early pregnancy:
OR=3.03), and criminality (e.g., violence: OR=3.52; Erskine et al., 2016). Despite these negative
outcomes, remarkably little is known about the etiology of CD; there is a relative paucity of
biological, and, in particular, genetic, research compared to other childhood neuropsychiatric
disorders such as attention-deficit/hyperactivity disorder (ADHD) and autism (Moffitt et al., 2008;
Salvatore & Dick, 2016). A more thorough understanding of the mechanisms underlying CD is
essential to improving treatment and prevention strategies.
Though twin studies suggest that CD is moderately heritable (h2~0.50; Polderman et al.,
2015), few replicable individual risk variants been identified (Salvatore & Dick, 2016). Most
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molecular genetic research on CD and related phenotypes has focused on candidate genes in known
biological systems (e.g., MAOA and SLC6A4; Holz et al., 2016; Salvatore & Dick, 2016; Veroude
et al., 2016), with some meta-analytic evidence for replicable main (Ficks & Waldman, 2014) and
gene-by-environment interaction (Byrd & Manuck, 2014) effects. Genome-wide association
studies (GWAS) of conduct disorder (Anney et al., 2008; Dick et al., 2011) and related phenotypes
(e.g., behavioral disinhibition: Derringer et al., 2015; aggression: Mick et al., 2011, and Pappa et
al., 2016; psychopathic/callous-unemotional [CU] traits: Viding et al., 2010, and Viding et al.,
2013; and antisocial personality disorder [ASPD]: Rautiainen et al., 2016, Salvatore et al., 2015,
and Tielbeek et al., 2012) have begun to identify suggestive and genome-wide significant (i.e.,
p<5E-08; Table 4.1) loci.
Table 4.1 Prior Genome-wide Association Studies of Conduct-disorder-related Phenotypes
Citation
Anney et al., 2008

Phenotype
CD diagnosis

N
208 cases,
730 controls

Significant SNPs
none

Significant Genes
-

Viding et al., 2010

psychopathic tendencies

300 cases,
300 controls

none

-

Dick et al., 2011

CD symptoms

3963
(872 cases,
3091 controls)

rs16891867,
rs7950811,
rs11838918,
rs1861046

-

Mick et al., 2011

behavior dysregulation

341

none

-

Tielbeek et al., 2012

antisocial behavior

4816
(298 cases,
4518 controls)

none

None

Viding et al., 2013

CU behavior

2930

none

-

Derringer et al., 2015

behavioral disinhibition

1901

none

MAGI2,
NAV2,
CACNA1C,
PCDH9, MYO16,
IQCH, DLGAP1

Salvatore et al., 2015

antisocial behavior

1379

none

ABCB1

Pappa et al., 2016

aggressive behavior

18,988

none

AVPR1A
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Rautiainen et al., 2016

ASPD

discovery:
370 cases,
5850 controls

rs4714329

-

replication:
173 cases,
3766 controls

One way in which genetic risk for conduct disorder may manifest phenotypically is through
abnormal neural responsiveness to social-emotional stimuli. Theoretical models (Blair, 2013;
Kiehl, 2006; Rubia, 2011) and recent meta-analyses (Alegria et al., 2016; Noordermeer et al.,
2016; Raschle et al., 2015) have emphasized a role for regions within the paralimbic system (e.g.,
orbitofrontal cortex, dorsolateral and medial prefrontal cortex, superior temporal cortex, insula,
and amygdala) associated with affect, motivation, and emotion processing. When viewing socialemotional stimuli (e.g., images of facial expressions or individuals in painful situations), for
example, individuals with CD, and especially those with comorbid psychopathic/callousunemotional (CU) traits, tend to show blunted responses in regions such as the amygdala and insula
(e.g., (Lockwood et al., 2013; Marsh et al., 2013; Passamonti et al., 2010), but see also (Fairchild
et al., 2014)). Despite this evidence, it is unclear whether group differences in these regions are
heritable neurobiological risk factors, correlates of environmental risk (e.g., childhood
maltreatment), or consequences of disorder expression. As with behavioral genetic studies of CD,
prior neurogenetic investigations have focused primarily on candidate genes (e.g., MAOA:
Buckholtz & Meyer-Lindenberg, 2008), and, to my knowledge, no imaging studies to date have
examined unaffected relatives of individuals with conduct disorder. As such, it remains uncertain
whether individual differences in activation within these brain regions represent genetically
influenced risk markers for CD.

51

In this study, I performed a GWAS of retrospectively reported DSM-IV CD diagnosis in a
sample of 1675 Australians of European ancestry from the Comorbidity and Trauma Study (CATS;
Nelson et al., 2016). I then tested whether genetic risk factors identified by the GWAS (i.e.,
genome-wide significant loci and polygenic risk scores) were also associated with self-reported
psychopathy constructs in a sample of 406 non-Hispanic Caucasian U.S. college students in the
Duke Neurogenetics Study (DNS; Corral-Frias et al., 2015). Finally, based on evidence that CD,
psychopathy, and related phenotypes are associated with blunted neural activity to emotional
expression in others (see Alegria et al., 2016, Noordermeer et al., 2016, and Rubia, 2011, for metaanalyses), I probed whether genetic risk for CD is associated with individual variability in brain
activity to emotional faces in the DNS sample.

4.2 Methods
4.2.1 Genome-wide Association Study
Participants
CATS participants of European ancestry (N=1675; Mage=36.25±9.13; 735 females) who had
genetic and CD diagnosis data were included in analyses. CATS is a case-control study of opioiddependent individuals (n=1232), aged 18 or older, who were recruited from clinics providing
opioid substitution therapy in the greater Sydney, Australia, region (Nelson et al., 2016). Nonopioid-dependent controls (n=443) were recruited from socially disadvantaged neighborhoods in
geographic proximity to locations where cases had been recruited. Institutional Review Board
approval was obtained from University of New South Wales, Washington University School of
Medicine, QIMR Berghofer Medical Research Institute, and Sydney area health service ethics
committees.
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Measures
DSM-IV CD diagnosis (ncase=680, ncontrol=995) was retrospectively assessed using a modified
version of the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA-OZ; Bucholz
et al., 1994; Heath et al., 2011). Consistent with a prior GWAS of CD that also utilized the SSAGA
(Dick et al., 2011), the DSM-IV criterion requiring temporal symptom clustering (i.e., symptoms
must co-occur within a six-month period) was not used, due to the retrospective nature of report.
The interview also assessed DSM-IV substance abuse and dependence, as well as other forms of
psychopathology (Table 4.2).
Table 4.2 CATS Sample Demographics
Variable
N
Age
Female
Conduct disorder
Conduct disorder sx
Opioid dependence
Alcohol dependence
Cannabis dependence
Cocaine dependence
Nicotine dependence
Sedative dependence
Stimulant dependence
PTSD
MDD
ASPD

Overall
1675
36.25(9.13)
43.9%
40.6%
3.28(2.61)
73.6%
38.0%
49.3%
23.8%
59.6%
28.5%
43.0%
33.7%
58.5%
39.2%

Cases
680
35.29(8.58)
35.3%
100%
5.49(2.09)
86.0%
49.3%
63.2%
31.9%
70.2%
39.0%
58.3%
43.0%
63.5%
96.1%

Controls
995
36.91(9.44)*
49.6%*
0%*
1.77(1.70)*
65.0%*
30.3%*
39.8%*
18.3%*
52.4%*
21.3%*
32.6%*
27.4%*
55.1%*
0%*

*Indicates a significant difference between cases and controls.
Note. All binary measures are reported in percentages. Continuous measures are presented as M(SD). CATS =
Comorbidity and Trauma Study. PTSD = Post-traumatic stress disorder. MDD = Major depressive disorder. ASPD =
Antisocial personality disorder.

Notably, suggestive that conduct problems were not secondary to problematic substance use in
this sample, onset of substance use disorders largely occurred after age 15, the upper limit for
conduct disorder diagnosis in CATS (Table 4.3).
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Table 4.3 CATS Substance Dependence Average Ages-of-Onset
Substance
Opioid
Alcohol
Cannabis
Cocaine
Nicotine
Sedative
Stimulant

Overall
22.94(6.50)
20.27(6.48)
19.83(5.90)
27.08(7.62)
21.20(6.37)
25.18(7.34)
22.78(6.95)

Cases
21.44(6.20)
19.05(6.11)
18.73(5.46)
25.95(7.17)
20.05(5.86)
23.57(7.12)
21.65(6.58)

Controls
24.30(6.47)*
21.62(6.61)*
21.02(6.13)*
28.41(7.95)*
22.24(6.63)*
27.17(7.13)*
24.14(7.14)*

*Indicates a significant difference between cases and controls.
Note. Measures are presented as M(SD).

Genetics
Genotyping was performed at Johns Hopkins Center for Inherited Disease Research (CIDR) using
the Illumina Human660W-Quad BeadChip. Following quality control and data cleaning
procedures (duplicate genotyping concordance=99.9%, Hardy-Weinberg equilibrium (HWE) pvalues >10-6, minor allele frequency (MAF) >0.01, SNP call and sample genotype rates>99%,
GenomeStudio quality score>0.7), 494,990 SNPs were available for analysis.
Ancestry-informative principal components (PCs) were generated using the smartpca
program (Patterson, Price, & Reich, 2006) within the EIGENSOFT package (v.5.0.1;
https://www.hsph.harvard.edu/alkes-price/software/). Consistent with prior genetic analyses of
this sample (Carey et al., 2015; Nelson et al., 2016), PCs within the top 10 which showed an
association with the outcome phenotype (i.e., CD diagnosis) were used in analyses to control for
occult population stratification.
Statistical Analyses
Associations between each autosomal SNP and CD diagnosis were tested using logistic regression
and an additive model in PLINK (v.1.07; Purcell et al., 2007). Covariates included sex, age
quintile, and four ancestry-informative principal components. Because childhood CD is highly
predictive of future substance involvement (Elkins, McGue, & Iacono, 2007), primary analyses
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were conducted without opioid dependence status as a covariate. Follow-up analyses with opioid
dependence case status as an additional covariate were then conducted.
Versatile Gene-based Association Study 2 (VEGAS2; Mishra & Macgregor, 2015)
software was used to conduct gene-based analyses by aggregating SNP-level summary statistics
across 24,769 autosomal RefSeq-annotated individual gene definitions, ±50kb in order to capture
promoter and flanking variants. Gene-level p-values were calculated using Monte Carlo
simulation, accounting for linkage structure based on the 1000 Genomes European reference panel.
The adjusted gene-based significance threshold, controlling for the number of genes tested, was
p<2.02E-06 (α=0.05 / 24,769 autosomal genes).
Bioinformatics Investigation of Variant-Associated Gene Expression
Genome-wide significant SNPs were probed for associations with gene expression in brain tissue
using data from the CommonMind Consortium (dorsolateral prefrontal cortex from 279 control
participants; http://commonmind.org; Fromer et al., 2016), UK Brain Expression Consortium’s
Brain eQTL Almanac (BRAINEAC; 10 brain regions [frontal cortex, occipital cortex, temporal
cortex, cerebellar cortex, hippocampus, intralobular white matter, medulla, putamen, thalamus,
substantia nigra] obtained from 134 individuals with no evidence of neurodegenerative disorder;
http://www.braineac.org/; Ramasamy et al., 2014), and Genotype-Tissue Expression project
(GTEx; 10 brain regions [anterior cingulate cortex, caudate, cerebellar hemisphere, cerebellum,
cortex, frontal cortex, hippocampus, hypothalamus, nucleus accumbens, putamen] available in ≥72
individuals; https://www.gtexportal.org; Lonsdale et al., 2013) in order to better understand
potential mechanisms of action.
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4.2.2 Neuroimaging Follow-Up
Participants
Data were available from 438 non-Hispanic Caucasian undergraduate student participants in the
DNS, as described in detail in Section 2.2.1. Participants were excluded for issues of quality
control: a large number of movement or signal intensity outliers in fMRI data (n=6), inadequate
coverage of the amygdala (n=10), poor behavioral accuracy (n=5), scanner/equipment malfunction
(n=6), experimenter error (n=1), incidental structural findings (n=2) and relatedness (n=2, removed
randomly from related pairs of participants). Following these exclusions, a final sample of 406
participants (Mage=19.75±1.25; 211 females) remained.
Measures
The 29-item Self-Report of Psychopathy-Short Form (SRP-SF; Paulhus, Neumann, & Hare, 2009)
was used to assess psychopathic traits. The SRP-SF has a known four-factor structure (Dotterer et
al., 2016), each consisting of seven items scored on a Likert scale from 1 (strongly disagree) to 5
(strongly agree). The Interpersonal subscale may be conceptualized as interpersonal manipulation
and consists of items such as “I would get a kick out of scamming someone” and “You can get
what you want by telling people what they want to hear.” The Affective subscale reflects callousunemotional traits and is composed of items such as “People sometimes say that I'm cold-hearted”
and “Most people are wimps.” The Lifestyle subscale reflects features such as recklessness and is
composed of items such as “I'm a rebellious person” and “I rarely follow the rules.” The Antisocial
subscale represents criminal tendencies and behavior and is composed of items such as “I have
tricked someone into giving me money” and “I have broken into a building or vehicle in order to
steal something or vandalize.” Subscale scores showed evidence of acceptable internal consistency
(αs=0.654-0.815) but were log-transformed to reduce positive skewness (Figure 4.1). Finally, to
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maintain variability but constrain the influence of extreme outliers, scores were winsorized (i.e.,
outliers more than M±3SDs [nAntisocial=5, all other subscales n=0] were set at ±3SDs from the mean)
prior to analyses.

Figure 4.1 Raw Distributions of SRP-SF Subscale Scores. Mean and standard deviation for each subscale are listed
below the corresponding histogram. Possible scores range from 5 to 35.

Genetics
DNA was isolated from saliva, genotyped, imputed, and subjected to quality assurance procedures,
after which polygenic risk scores (PRS; Purcell et al., 2009) based on the CATS CD GWAS results
were generated, and genome-wide significant variants extracted, for analysis. Non-Hispanic
Caucasian ancestry was confirmed and proper controls for population stratification were generated
using identity by state analysis and multidimensional scaling (MDS) in PLINK (v.1.07; Purcell et
al., 2007). Further details of these procedures are available in Section 2.2.3.
Neuroimaging
Blood oxygen level-dependent functional magnetic resonance imaging (BOLD fMRI) data were
acquired while participants completed an emotional face-matching paradigm (Figure 4.2; Carre,
Hyde, Neumann, Viding, & Hariri, 2013), consisting of four expression-specific (i.e., Neutral,
Angry, Fear, Surprise) face-matching task blocks interleaved with five sensorimotor shapematching control blocks.
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Figure 4.2 BOLD fMRI Corticolimbic Reactivity Paradigm. A) Participants completed four expression-specific
(Neutral, Angry, Fear, Surprise) face-matching task blocks interleaved with five sensorimotor shape-matching control
blocks. Order for task blocks was counterbalanced across participants. B) Depiction of one face-matching trial (in red)
and one shape-matching trial (in blue).

Order for task blocks was counterbalanced across participants. In each face-matching trial within
a block, participants viewed a trio of faces derived from a standard set of facial affect pictures
(Ekman & Friesen, 1975) and selected which of two faces presented on the bottom row of the
display matched the target stimulus presented on the top row. Each emotion-specific block (e.g.,
fearful facial expressions only) consisted of six individual trials, balanced for gender of the face.
Block order was pseudo-randomized across participants. Each of the six face trios was presented
for 4 seconds with a variable inter-stimulus interval of 2-6 seconds; total block length was 48
seconds. In the shape-matching control blocks, participants viewed a trio of geometric shapes (i.e.,
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circles, horizontal and vertical ellipses) and selected which of two shapes displayed on the bottom
matched the target shape presented on top. Each control block consisted of six different shape trios
presented for 4 seconds with a fixed inter-stimulus interval of 2 seconds, comprising a total block
length of 36 seconds.
Information regarding BOLD fMRI acquisition and preprocessing procedures is available
in Section 2.2.4. Following preprocessing, linear contrasts employing canonical hemodynamic
response functions were implemented using the general linear model of Statistical Parametric
Mapping 8 (SPM8; http://www.fil.ion.ucl.ac.uk/spm) to estimate effects of condition (i.e., neutral
faces, angry faces, fearful faces, surprised faces, and shapes blocks) for each participant. Contrast
images for All Faces Blocks > Shapes Blocks, which reflects broad reactivity to emotionally salient
facial stimuli, were then calculated for each participant for use in second-level whole-brain
regressions.
Statistical Analyses
A series of linear regressions tested whether genetic risk for CD (i.e., genome-wide significant
polymorphisms and PRS from the CATS GWAS), was associated with individual differences in
self-reported psychopathy (i.e., SRP-SF Interpersonal, Affective, Lifestyle, and Antisocial
subscales). I made no a priori predictions regarding which of the four SRP-SF factors would be
associated with CD genetic risk and thus treated these analyses as exploratory.
Associations between CD genetic risk and neural reactivity to emotional faces were
assessed at the whole-brain level in SPM8. All Faces Blocks > Shapes Blocks contrast images for
each participant were entered into a second-level multiple regression model with CD genetic risk
as the covariate of interest. PRS were calculated at the P-value threshold of P<0.50 based on the
CATS CD GWAS to maximize the number of variants included while requiring some evidence of
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association; post hoc tests at other P-value thresholds were also conducted. To correct for multiple
comparisons, significant regions of activation were required to meet a voxel-wise p<0.05 FWE
threshold and a cluster extent threshold of 10 contiguous voxels.
Sex and two ancestry-informative MDS components were entered as covariates of no
interest for all analyses.

4.3 Results
3.3.1 Genome-wide Association Study
One variant, rs12536973 (A/G; call rate=0.998, HWE p=0.271, MAF=0.113) in an intergenic
region on chromosome 7, attained genome-wide significance (p=3.74E-08), with several other
independent signals suggestive of association (i.e., p<1E-05; Table 4.4; Figure 4.3). At the top
locus, the number of minor G alleles was associated with relatively decreased odds (i.e., 0.505,
95% CI[0.396, 0.644]) of CD diagnosis.
Table 4.4 SNPs Associated with Conduct Disorder Diagnosis in CATS Participants (p<1E-05)
SNP
rs12536973
rs1928228
rs1595146
rs7893421
rs10974824
rs8045276
a

Chr
7
9
4
10
9
16

BP
10062341
88698820
29316636
72991385
4869801
29025978

Gene
Intergenic
GOLM1
Intergenic
UNC5B
Intergenic
Intergenic

A1a
G
A
G
A
A
A

A2
A
C
A
G
C
G

A1 Freq
0.11
0.11
0.42
0.44
0.06
0.30

OR [95% CI]
0.51 [0.40, 0.64]
0.53 [0.41, 0.67]
0.71 [0.61, 0.82]
0.72 [0.62, 0.83]
0.47 [0.34, 0.65]
0.70 [0.59, 0.82]

P-value
3.74E-08
3.56E-07
4.74E-06
5.59E-06
6.72E-06
7.23E-06

A1 denotes the minor allele in our sample. ORs were calculated using A1 as the effect allele.
P-value when covarying for opioid dependence status.

b
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P-value, ODb
5.74E-08
3.95E-07
5.48E-06
1.48E-05
1.12E-05
4.96E-06

Figure 4.3 Manhattan Plot of Results from the Conduct Disorder GWAS. Suggestive association threshold (i.e.,
p< 1E-05) is indicated by the blue line; GWAS significance threshold (i.e., p<5E-08) is indicated by the red line.
Figure was created using HaploView (https://www.broadinstitute.org/haploview/; (Barrett, Fry, Maller, & Daly,
2005)).

Annotation analyses revealed no strong evidence that rs12536973 genotype or SNPs in LD
with it are associated with differential gene expression. There was a nominally significant
association between rs12536973 genotype and PHF14 expression in prefrontal tissue within the
CommonMind Consortium (dorsolateral prefrontal cortex: β=0.020, p=0.019, uncorrected) and
BRAINEAC (t2990043; frontal cortex; p=0.045, uncorrected; but not other regions, all ps>0.20)
databases, wherein the A allele—the “risk” allele in the CD GWAS—was associated with
relatively increased PHF14 expression. However, this relationship did not approach significance
when accounting for multiple testing across genes and brain regions and was not even nominally
significant within GTEx.
Gene-based tests revealed one gene, GOLM1, associated with CD diagnosis (p=2.00E-06;
see Table 4.5 for the top 10 gene-based associations). Within GOLM1, 13 of 23 SNPs were
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nominally associated (i.e., p<0.05) with CD, with the strongest evidence of association at
rs1928228 (p=3.56E-07; Figure 4.4).
Table 4.5 Top 10 Gene-level Associations in CATS
Gene
GOLM1
NAA35
MIR101-2
RCL1
GGH
LOC100144595
LOXL4
MIR4515
BTBD1
C5orf49

Chr
9
9
9
9
8
2
10
15
15
5

Starting BP
88591057
88506056
4800296
4742833
63877638
155242364
99957442
83686086
83635180
7780490

Ending BP
88765116
88687217
4900375
4911077
64001610
155363950
100078007
83786167
83786106
7901603

# SNPs
23
19
47
67
17
48
24
11
13
42

Gene-level P-value
2.00E-06
3.00E-06
6.00E-05
9.20E-05
1.71E-04
2.15E-04
3.26E-04
0.000328
0.000337
0.000376

Note. Associations surviving correction for multiple comparisons are bolded. Base pair positions for each gene extend
50kb from the 5’ and 3’ UTR.

Figure 4.4 Regional Association Plot for All SNPs within GOLM1. The x-axis represents the position of each SNP
on chromosome 9. In the scatterplot, the y-axis is the negative log of the p-value of each association. Colors indicate
linkage patterns with the most significant SNP in the region, rs1928228, whereby warmer colors represent higher r 2
values, while cooler colors represent lower R2 values. The recombination rate across the region, based on HapMap
data, is represented by the solid blue line. Figure was created using LocusZoom (http://locuszoom.org/; Pruim et al.,
2010).
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Replication of Prior Associations
Following these exploratory analyses, prior published SNP- and gene-level associations (Table
4.1) were queried for significance in the current sample. Of all previously identified SNPs, only
one variant, rs4714329 (A/G; call rate=1.000, HWE p=0.614, MAF=0.410) in an intergenic region
on chromosome 6, attained nominal significance (i.e., p=0.022; Table 4.6). As in the original paper
(Rautiainen et al., 2016), the number of minor G alleles was associated with relatively increased
odds (i.e., 1.184, 95% CI[1.024, 1.369]) of CD diagnosis. No prior gene-level associations were
replicated in the current sample (Table 4.7).
Table 4.6 Conduct Disorder Associations with Previously-Identified SNPs
Citation
Dick et al., 2011b

SNP
rs1861046
rs7950811
Rautiainen et al., 2016 rs4714329

Chr
4
11
6

BP
15397906
92651002
40273457

A1a
A
A
G

A2
G
C
A

A1 Freq
0.03
0.04
0.41

Original OR
1.65
1.65
1.59

OR [95% CI]
0.77 [0.51, 1.16]
0.83 [0.58, 1.19]
1.18 [1.02, 1.37]

P-value
0.21
0.31
0.02

a

A1 denotes the minor allele in our sample. ORs were calculated using A1 as the effect allele.
Dick et al., 2011, meta-analyzed across both European-American and African-American subsamples. In EuropeanAmerican ancestry, rs1861046 and rs16891867 are in perfect LD, and rs11838918 is not represented.
b

Table 4.7 Conduct Disorder Associations with Previously-Identified Genes
Citation
Derringer et al., 2015

Salvatore et al., 2015
Pappa et al., 2016

Gene
MAGI2
NAV2
CACNA1C
PCDH9
MYO16
IQCH
DLGAP1
ABCB1
AVPR1A

Chr
7
11
12
13
13
15
18
7
12

Starting BP
77596373
19322270
2112415
66826965
109198499
67497137
3446029
87083178
63486538

Ending BP
79132890
20193147
2857115
67854468
109910355
67844142
4505266
87392639
63596590

# SNPs
479
306
188
186
179
21
279
76
22

Gene-level p-value
0.68
0.39
0.24
0.77
0.17
0.08
0.57
0.39
0.87

Note. Base pair positions for each gene extend 50kb from the 5’ and 3’ UTR.

4.3.2 Neuroimaging Follow-Up
The genome-wide significant SNP in the CD GWAS, rs12536973, was extracted for analysis in
the DNS (directly genotyped, call rate=0.995; HWE p=1.000, MAF=0.116; n=404). Due to low
MAF, minor allele homozygotes (nGG=6) were combined with heterozygotes (nAG=82) to form one
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group of “CD-protected” minor allele carriers (nAG/GG=88), who were compared to major allele
homozygotes (nAA=316).
Consistent with the CATS GWAS results, rs12536973 A allele homozygotes had greater
SRP-SF Lifestyle scores relative to G allele carriers (β=0.123, ΔR2=0.015, p=0.010). No other
subscales (i.e., Affective, Antisocial, or Interpersonal) were associated with rs12536973 genotype
(i.e., ps>0.40; Table 4.6).
Table 4.6 Top GWAS Hit Associations with SRP-SF Scores in DNS
Subscale
Interpersonal
Affective
Lifestyle
Antisocial

β
0.039
0.017
0.123
0.016

ΔR2
0.001
0.000
0.015
0.000

P
0.420
0.709
0.010
0.740

PRS derived from the CD GWAS were nominally associated with the SRP-SF Antisocial subscale
(significant at 3 of 10 P-value thresholds; largest effect at P<0.10: β=0.116, ΔR2=0.013, p=0.019;
Figure 4.5), but not with Lifestyle or other subscales (i.e., ps>0.08).

Figure 4.5 Associations between CD PRS and SRP-SF Subscales in the Duke Neurogenetics Study. Y-axis is the
percent of variation in the outcome measure explained by CD PRS. Positive values indicate a positive association
between CD PRS and the outcome. Negative values are for display purposes only and indicate a negative association.
Shades of gray in legend indicate the P-value threshold at which the risk score was calculated.
*p<0.05, +p<0.10

Repetition of analyses with raw (i.e., non-winsorized, untransformed) data did not substantively
alter results.
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Despite significant associations with SRP-SF Lifestyle scores, rs12536973 genotype was
not associated with differential neural activity to All Faces Blocks > Shapes Blocks when
accounting for multiple comparisons at the voxel-wise level. Increased genome-wide polygenic
risk for CD, however, was associated with decreased left insula activity (max voxel Montreal
Neurological Institute [MNI] coordinates=[-32, 2, 14], k=13, t=4.95, whole-brain voxel-wise
p<0.05 FWE; Figure 4.6).

Figure 4.6 Associations between CD PRS and Whole-brain Activity to Emotional Faces. CD PRS were associated
with decreased activity within a cluster in the left insula (max voxel MNI coordinates=[-32, 2, 14], k=13, t=4.95, p<
0.05 FWE). No clusters were positively associated with PRS. PRS were calculated based on variants meeting a
threshold of P<0.50 in the original GWAS.

Notably, post hoc analyses revealed that this cluster was associated with CD PRS at 7 of 10 Pvalue thresholds using a p<0.005 whole-brain uncorrected threshold (Figure 4.7).
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Figure 4.7 Associations between CD PRS and Whole-brain Activity to Emotional Faces Across All P-value Thresholds. Images are presented at the
coordinates of the maximum voxel in our primary analysis (P-value threshold of P<0.50: max voxel MNI coordinates=[-32, 2, 14], k=13, t=4.95, p<0.05 FWE)
and are thresholded at p<0.005, uncorrected.
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Because PRS were associated with increased SRP-SF Antisocial subscale scores as well as
decreased activity in the insula during the face-matching task, I undertook a post hoc conjunction
analysis to investigate whether left insula activity, or activity in any other regions, may be
associated with both CD PRS and SRP-SF Antisocial scores. As in prior research (Mioshi, Hodges,
& Hornberger, 2013), I overlaid statistical maps, each thresholded at p<0.005, uncorrected, from
independent whole-brain regressions conducted in SPM8 with CD PRS and SRP-SF Antisocial
scores as covariates of interest, respectively, in xjView (http://www.alivelearn.net/xjview), which
revealed overlapping activation clusters in the bilateral insula and supramarginal gyri (Figure 4.8).

Figure 4.8 Brain Regions Associated with Both CD PRS and SRP-SF Antisocial Scores. The highlighted regions
represent the conjunction of those clusters, within the bilateral A) insula and B) supramarginal gyri, negatively
associated with CD PRS and SRP-SF Antisocial at a threshold of p<0.005, uncorrected. No overlap occurred for
positively-associated regions.
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4.4 Discussion
In this study, analyses identified one genome-wide significant variant, rs12536973, and one genelevel significant gene, GOLM1, associated with conduct disorder in a discovery GWAS dataset of
1675 Australians of European ancestry (ncase=680, ncontrol=995). Providing preliminary evidence
of extension to subclinical trait variation, rs12536973 genotype and PRS generated from GWAS
summary statistics were also associated with individual differences in psychopathy among an
independent sample of 406 non-Hispanic Caucasian U.S. college students who completed a
neuroimaging protocol. Exploratory whole-brain analyses in the extension sample further
demonstrated that polygenic risk for CD is associated with blunted left insula activity to emotional
faces, and a post hoc conjunction analysis showed that decreased bilateral insula and
supramarginal gyrus activation is linked to both CD polygenic risk and self-reported psychopathy,
providing a putative neural mechanism through which polygenic risk for CD may be
phenotypically expressed.

4.4.1 Genetic Associations with Conduct Disorder
The major A allele at rs12536973 was associated with increased rates of CD in the discovery
GWAS, as well as with higher self-reported SRP-SF Lifestyle scores (e.g., “I'm a rebellious
person” and “I rarely follow the rules”) in the extension sample. This locus resides in an intergenic
region on chromosome 7 (7p21.3) between LOC340268, the C3 and PZP-like, alpha-2macroglobulin domain containing 8 pseudogene, and HSPA8P8, the heat shock protein family A
(Hsp70) member 8 pseudogene 8. Though the variant itself is noncoding, functional annotation
using multiple brain tissue databases provided preliminary (i.e., nominally significant in two
datasets without correction for multiple testing) evidence that rs12536973 may be associated with
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differential PHF14 expression in the prefrontal cortex. While the function of PHF14 is poorly
understood, it belongs to the class of highly conserved plant homology domain (PHD) finger
transcription factor genes, which code for proteins structurally equipped to read the sequencedependent methylation state of H3K4 histones (Sanchez & Zhou, 2011). However, the links
between PHF14 expression and externalizing behaviors are unknown, and the current results
linking the CD GWAS-significant variant to PHF14 expression should be considered speculative
at best given the nominal nature of the association.
Gene-based analyses revealed one gene, GOLM1, the Golgi membrane protein 1, showing
significant signal enrichment, and another nearby gene, NAA35, the N(alpha)-acetyltransferase 35,
NatC auxiliary subunit, which was suggestive of association. Both are located at 9q21.33, and in
gene-based analyses including ±50kb from defined gene boundaries, 9 SNPs were shared between
analytic sets. However, repetition of analyses without extending gene boundaries to include
promotor and flanking regions did not substantially alter empirical p-values (i.e., GOLM1
p=2.00E-06, NAA35 p=2.91E-05), indicating that the NAA35-GOLM1 region as a whole is likely
associated with CD. Interestingly, prior research has linked both GOLM1 and NAA35 to
neuropsychiatric phenotypes: GOLM1 with Alzheimer’s disease (H. Li et al., 2008), schizophrenia
(Mudge et al., 2008), and prefrontal cortex volume (Inkster et al., 2012), and NAA35 with alcohol
use (Pan et al., 2013; Rodd et al., 2008). These findings suggest that the NAA35-GOLM1 region,
and GOLM1 in particular, may affect cognition in a broad manner, though the molecular
mechanism remains to be explored.
None of the top GWAS hits (i.e., rs12536973, which was genome-wide significant, and the
five other suggestive GWAS associations, p<1E-05; Table 4.4) or gene-level associations (i.e.,
GOLM1 and the other nine most significant associations; Table 4.5) have been previously
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identified in prior association or linkage studies of conduct disorder or related phenotypes (see
Table 4.1 for prior significant associations and the cited studies therein for lists of suggestive
associations). Examination of previously-identified genes and SNPs in our sample revealed
nominal evidence of replication (i.e., p=0.022) for rs4714329 (Table 4.6), which had originally
been associated with ASPD diagnosis in a meta-analysis of two samples (Rautiainen et al., 2016).
Given that CD is a diagnostic prerequisite for ASPD, and in our phenotypically extreme sample
96.1% of individuals with CD in childhood qualified for a diagnosis of ASPD at the time of the
interview, replication of this association provides further evidence for a role of rs4714329 in
antisocial behavior across the lifespan.

4.4.2 Neuroimaging Extension
Polygenic risk for CD was negatively associated with left anterior insula activation to the
emotional face-matching task and positively coupled with SRP Antisocial subscale scores (e.g., “I
have tricked someone into giving me money” and “I have broken into a building or vehicle in order
to steal something or vandalize”). The insula is involved in interoceptive awareness, decisionmaking, empathy, and overall social-emotional processing (Craig, 2009; Gu et al., 2013; Lamm &
Singer, 2010; Mutschler et al., 2013; Naqvi & Bechara, 2009), and has been repeatedly implicated
in studies of conduct disorder and related phenotypes (Alegria et al., 2016; Hyde, Shaw, & Hariri,
2013; Noordermeer et al., 2016; Raschle et al., 2015; Rogers & De Brito, 2016; Rubia, 2011). One
meta-analysis identified the left insular cortex as one of two regions (the other being the right
dorsomedial prefrontal cortex) associated with differences across both structural and functional
imaging modalities among adolescents exhibiting aggressive behavior (Raschle et al., 2015).
Perhaps most relevant to the current study, the insula is essential to “affective empathy” (i.e., the
vicarious experience of the emotions of others; Lockwood, 2016). For example, one study found
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that in-scanner ratings of affective responses to emotional faces correlated with anterior insula
activity, and, further, that such activity was negatively associated with SRP-SF Lifestyle-Antisocial
scores, mirroring our subscale-specific observations (Seara-Cardoso, Sebastian, Viding, & Roiser,
2016). Moreover, passive viewing of emotional or painful video clips elicits relatively lower insula
activation in psychopathic (Meffert, Gazzola, den Boer, Bartels, & Keysers, 2013) and offender
(Arbuckle & Shane, 2016) populations, an effect that is normalized upon instruction to “feel” or
empathize with the actors in the videos. In the context of these prior studies, the current results
suggest that blunted left insula activation may be a neural mechanism through which genomic risk
for CD confers less spontaneous affective empathy, and, in turn, increased antisocial behavior.
The post hoc conjunction analysis revealed that, in addition to the insula, activation in the
supramarginal gyrus was also negatively associated with both CD polygenic risk and SRP-SF
Antisocial scores. While this result should be interpreted with caution, as associations with CD
PRS at the whole-brain level in this region did not survive family-wise error correction, several
studies have linked CD and related phenotypes to differences in supramarginal gyrus structure
(Huebner et al., 2008; Hyatt, Haney-Caron, & Stevens, 2012), function (Decety, Skelly, & Kiehl,
2013; Klapwijk et al., 2016; Meffert et al., 2013), and connectivity (Philippi et al., 2015). As with
the insula, it has been associated with spontaneous vicarious representations of pain and emotion
(Arbuckle & Shane, 2016; Meffert et al., 2013; Seara-Cardoso et al., 2016). In addition to affective
representation, it also plays a role in self-other processing and perspective-taking (i.e., “cognitive
empathy”; Bird & Viding, 2014; Hooker, Verosky, Germine, Knight, & D'Esposito, 2010),
specifically in resolving conflicts between one’s own mental state and the mental states of others
(Silani, Lamm, Ruff, & Singer, 2013). Taken together, while speculative, a genetic predisposition
to hypoactivation of the insula and supramarginal gyrus in response to social-emotional signals
71

may result in a lack of affective representation combined with a diminished ability to process
others’ perspectives, causing a fundamental breakdown of empathic responding. Such an
interpretation is strengthened by the fact that this relationship exists in the relatively healthy DNS
sample, with minimal CD expression or enrichment of associated environmental confounds (e.g.,
childhood trauma, illicit drug use).

4.4.3 Limitations
These results must be interpreted in the context of several limitations. First, the discovery GWAS
sample (N=1675) was underpowered to detect the small individual-variant effect sizes typically
seen in studies of complex traits (Sullivan, Daly, & O'Donovan, 2012). However, because the
CATS sample was recruited for opioid dependence, it is enriched for CD as well as extreme
presentations (i.e., 40.6% cases in our study vs. 22.0% cases in Dick et al., 2011, and 2.1% in the
general population, Polanczyk et al., 2015; cases reporting 5.49±2.09 DSM-IV conduct disorder
symptoms in this study vs. 4.62±3.48 in Dick et al., 2011, p<0.001). This may result in larger
observed effect sizes than expected in non-extreme-case designs (CONVERGE Consortium,
2015). While this design potentially limits generalizability of the current results, the observation
of a consistent association in a high-achieving college sample provides further support for the
initial findings.
Second, regarding assessment, conduct disorder diagnosis was reached via retrospective
self-report and may thus be subject to memory biases. Additionally, though conduct disorder was
assessed in our neuroimaging extension sample, no participants met its criteria and minimal
symptoms were endorsed. This precluded a more direct replication attempt of genetic associations
with CD diagnosis and instead led me to examine individual differences in self-reported
psychopathy. While this approach resulted in greater variation than using a binary diagnostic
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variable, scores were still positively skewed in the DNS sample (Figure 4.1). Arguably, the lack
of severe conduct disorder-related symptoms in the neuroimaging sample is a strength, particularly
alongside the severe CD presentation in CATS, as it allowed me to explore relationships with
neural regions without the confound of disorder expression. Nonetheless, it remains a caveat, along
with small sample size (N=406), in any attempts to frame my extension results, though consistent
with those of the original CD GWAS, as a replication.
Third, the analyses performed in this study were exploratory in nature and thus require
future replication. Though I have attempted to control the Type I error rate in all mass univariate
analyses within this study (i.e., genome-wide, gene-level, and whole-brain association) and
denoted where results did not meet stringent correction thresholds (i.e., polygenic association with
psychopathy subscales and brain-tissue-specific gene expression at the top GWAS locus),
replication remains the gold standard of evidence, particularly in fields such as psychiatric and
imaging genetics that have been plagued by recent high-profile replicability crises (Ryan Bogdan
et al., 2017; Duncan & Keller, 2011). Overall, the results presented in this study should be
considered convergent and suggestive yet preliminary.
Finally, the phenotypic and genetic architecture of CD is complex and likely reflects
multiple possibly independent factors. A prior twin study, for example, suggested that two genetic
factors, reflecting rule-breaking and aggression, influence risk for conduct disorder (K. S. Kendler,
Aggen, & Patrick, 2013), consistent with a prior factor analysis indicating the presence of
aggressive and non-aggressive subtypes (Tackett, Krueger, Sawyer, & Graetz, 2003). Furthermore,
fewer than half of individuals with CD meet criteria for the new DSM-5 modifier “with limited
prosocial emotions,” meant to reflect callous-unemotional traits such as lack of remorse/guilt and
reduced empathy traditionally representative of psychopathy (Frick, Ray, Thornton, & Kahn,
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2014). Children and adolescents exhibiting callous-unemotional traits are at increased risk for the
development of ASPD in adulthood, as well as numerous related adverse outcomes (Blair,
Leibenluft, & Pine, 2014). Due to limited discovery sample size and use of DSM-IV diagnostic
criteria, it was not feasible to examine potentially different genetic influences on these subtypes,
though association of the top GWAS hit and polygenic risk scores with the SRP-SF Lifestyle and
Antisocial scales, respectively, but not Interpersonal or Affective scores, suggests some specificity
to behavior. Future genetic and neuroimaging studies may wish to interrogate distinct CD-related
presentations in order to identify general and subtype-specific risk markers.

4.4.4 Conclusion
In the current study, I linked a novel genome-wide significant locus, rs12536973, and the NAA35GOLM1 genomic region to CD based on a GWAS of severe CD presentations. The top locus and
polygenic risk for CD derived from the discovery GWAS were further associated with individual
differences in self-reported psychopathy constructs. Lastly, both polygenic risk for CD and selfreported psychopathy were associated with blunted activity in overlapping clusters within the
bilateral insula and supramarginal gyri during an emotional face-matching paradigm. These results
suggest that blunted neural responses to social-emotional stimuli in brain regions previously linked
to individual differences in empathy may represent a potential neural mechanism through which
genomic risk may promote the expression of CD.
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Chapter 5:
General Discussion
5.1 Overall Summary
Overall, this series of three studies probed the neural and genetic risk mechanisms underlying
externalizing spectrum disorders (Figure 1.1; Beauchaine & McNulty, 2013; Beauchaine et al.,
2017), which are characterized primarily by disinhibition and thought to be linked by a continuous
latent construct (Hicks et al., 2004; Krueger et al., 2002; Krueger et al., 2007; Krueger et al., 2005;
Markon & Krueger, 2005; Young et al., 2000). In Chapter 2, increased reward-related ventral
striatum activity was shown to be associated with both genetic risk for childhood ADHD and
problematic alcohol use in young adulthood, consistent with these disorders arising from a
common mechanism. Chapter 3 complemented the results of Chapter 2 by showing that
heightened reward-related VS activity in early adolescence, a critical developmental period,
prospectively predicts early versus late onset of drinking. In Chapter 4, genetic risk for conduct
disorder, quantified based on a genomewide association analysis, also predicted self-reported
psychopathy and blunted insula activity during social-emotional processing among healthy college
students, indicative of a common genetic architecture underlying both normal and pathological
variation. Taken together, these findings identify putative genetically influenced neural
mechanisms underlying externalizing psychopathology, shed light on the nature of premorbid risk
versus downstream disorder-related consequences, and provide further evidence for a continuous
relationship between ESDs and normal trait variation.
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5.1.1 Neurogenetic Mechanisms
Across the three studies, two neural mechanisms linking genetic risk to externalizing pathology
emerged: heightened reward-related VS activity (Chapters 2 and 3), and blunted anterior insula
activity during social-emotional processing (Chapter 4). In each case, polygenic risk for an ESD
(i.e., ADHD in Chapter 2 and CD in Chapter 4) was linked to differential neural activity (i.e.,
heightened reward-related VS activity and blunted anterior insula activity to emotional faces,
respectively), which was then linked to subclinical externalizing behaviors (i.e., drinking patterns
in Chapters 2 and 3 and self-reported psychopathy in Chapter 4, respectively). As such, these
differences in relative task-evoked regional activation represent strong candidate intermediate
externalizing phenotypes.
Reward-related Ventral Striatum Activation
The ventral striatum is a subcortical region consisting of the nucleus accumbens, ventral portions
of the caudate and putamen, and olfactory tubercle (Voorn, Vanderschuren, Groenewegen,
Robbins, & Pennartz, 2004). It is a key component of the mesolimbic dopamine pathway, receiving
input from the ventral tegmental area, basolateral amygdala, hippocampus, orbitofrontal cortex,
ventromedial prefrontal cortex, anterior cingulate, and thalamus (Alexander, Crutcher, & DeLong,
1990; Cardinal, Parkinson, Hall, & Everitt, 2002; Haber & Knutson, 2010). It has been implicated
in reward processing, motivation, incentive salience, and the subjective experience of pleasure (see
Berridge & Kringelbach, 2015, and Haber & Knutson, 2010, for reviews). Given prior associations
with multiple forms of externalizing pathology (e.g., ADHD, Plichta & Scheres, 2014; DBDs,
Alegria et al., 2016, and Noordermeer et al., 2016; and AUD/SUD, Balodis & Potenza, 2015, and
Hommer et al., 2011) and subclinical variation (e.g., drinking behavior, Weiland et al., 2016; and
trait impulsivity, Kennis et al., 2013), as well as indirect links to two ESDs (i.e., ADHD through
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genetic risk [Chapter 2] and AUD through normal variation in drinking behaviors [Chapters 2
and 3]) in the current studies, abberrant reward-related VS activation may represent a general
transdiagnostic externalizing risk factor (see Beauchaine et al., 2017, for review).
Social-emotional Anterior Insula Activation
The insula is a lobe of the cerebral cortex situated deep within the Sylvian fissure, or lateral sulcus,
which divides the frontal and parietal lobes from the temporal lobe (Reil, 1809; Türe, Yaşargil,
Al-Mefty, & Yaşargil, 1999). It is further divided into anterior and posterior sections by the central
insular sulcus (Flynn, 1999). The anterior portion has reciprocal connections to paralimbic regions
including the anterior cingulate, ventromedial prefrontal cortex, temporal lobe, amygdala, and
ventral striatum (Flynn, 1999; Naqvi & Bechara, 2009). Structurally, it has been linked to general
psychopathology (Goodkind et al., 2015), including alcohol use disorders (Yang et al., 2016) and
conduct problems (Raschle et al., 2015; Rogers & De Brito, 2016); functionally, it has been linked
to a wide range of cognitions, including decision-making (Naqvi & Bechara, 2009), interoception
(Craig, 2009), empathy (Mutschler et al., 2013), and overall social-emotional processing (Gu et
al., 2013; Lamm & Singer, 2010; Mutschler et al., 2013). Consistent with prior literature showing
blunted anterior insula activation to emotion-processing and empathy tasks among youth with
conduct problems (Alegria et al., 2016; Noordermeer et al., 2016; Raschle et al., 2015), criminal
offenders (Arbuckle & Shane, 2016), and adults with psychopathy (Meffert et al., 2013, but see
also Decety et al., 2013), the results of Chapter 4 indicate that it is further associated with genomewide genetic risk for CD as well as self-reported antisocial behavior (e.g., “I have tricked someone
into giving me money” and “I have broken into a building or vehicle in order to steal something
or vandalize”). Though I only investigated social-emotional processing activation in the context
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of CD genetic risk and psychopathy, prior reviews suggest this functional impairment may be
specific to antisocial behavior and psychopathy relative to other ESDs (Rubia, 2011).

5.1.2 Premorbid Risk vs. Downstream Disorder Consequences
A major limitation of prior studies of ESDs, particularly in neurimaging, has been confounds of
disorder expression. Cross-sectional case-control studies do not allow one to disentangle
premorbid risk from “environmental” correlates of disorder expression (e.g., substance or
medication use and experience of living with a disorder). The current studies relied upon two
complementary approaches to circumvent such issues: longitudinal data (i.e., Chapter 3) and
indices of genetic risk in healthy samples (i.e., Chapters 2 and 4). Chapter 2, for example,
provided evidence that genome-wide genetic risk for childhood ADHD, which is fixed at birth, is
associated with heightened ventral striatum activity to monetary reward, which is, in turn, related
to greater problematic alcohol use. Supplemental analyses with baseline nondrinkers provided
preliminary evidence that such activity prospectively predicted alcohol use initiation, and analyses
with longitudinal data in Chapter 3 demonstrated a prospective association between heightened
VS activity and early vs. late age-at-first-drink, which has previously been shown to predict future
problem drinking (DeWit et al., 2000).
Prior investigations of reward-related VS activation have yielded mixed results (Balodis &
Potenza, 2015; Hommer et al., 2011), though mounting evidence suggests that heightened VS
activity is associated with early stages of substance use (i.e., initiation and escalation; Heitzeg et
al., 2014; Stice et al., 2013; Weiland et al., 2016), but that decreased VS activity is associated with
later stages (i.e., compulsive use; Koob, 2013; Koob & Le Moal, 2005) and influenced by repeated
use of substances (Martz et al., 2016; Volkow et al., 2004). Results from Chapters 2 and 3 are
consistent with such an interpretation, as heightened VS activation was associated with both age78

at-first drink (Chapter 3) and normal variation in problem drinking (Chapter 2), though I was
unable to test whether sustained alcohol use may subsequently decrease activation (but see also
Appendix A for some preliminary evidence). By using both genetically informed and longitudinal
designs across two separate studies, I have provided additional evidence that increased rewardrelated VS activation is indeed a premorbid risk factor for alcohol (mis)use, and is also influenced
by genetic risk for another ESD: ADHD.

5.1.3 ESDs as Quantitative Traits
In contrast to most prior studies of ESDs, which have relied upon diagnosed cases and matched
controls, only one of the three samples utilized in the current studies (i.e., Chapter 4) was
clinically ascertained. This choice reflects both a desire to eliminate confounds of disorder
expression in the neuroimaging samples (see Section 5.1.2), as well as a growing understanding
in the fields of neuroimaging and genetics that psychiatric disorders represent extremes of normal
variation in quantitative traits (Marquand, Rezek, Buitelaar, & Beckmann, 2016; Plomin et al.,
2009). Both genetic risk and phenotypic expression for disorders are thought to be normally
distributed in the population, with those individuals with high enough genetic and phenotypic
loading qualifying for a diagnosis. The externalizing spectrum, as its name implies, adopts this
conceptualization of ESDs as representing extremes of quantitative traits; factor analyses have
shown both ESD diagnoses and related continuous traits (e.g., impulsivity, aggression, and [lack
of] empathy) to load on one higher-order continuous latent externalizing construct (Krueger et al.,
2002; Krueger et al., 2007; Krueger et al., 2005; Krueger & South, 2009; Markon & Krueger,
2005).
Chapters 2 and 4 explicitly relied upon the assumption of continuous genetic and
phenotypic risk through their use of polygenic risk scores (S. M. Purcell et al., 2009). In the
79

absence of family history and/or diagnostic data, risk scores generated based on results from a
GWAS provide a quantitative measure of genome-wide genetic risk for a particular disorder. In
Chapter 2, I demonstrated that PRS for childhood ADHD are associated with heightened VS
activity to reward, which consequently was associated with greater self-reported problem drinking.
In Chapter 4, based on the results of my discovery GWAS of CD, I showed that genome-wide
polygenic risk, in addition to genotype at the top locus, was associated with both self-reported
psychopathy and blunted insula activation to emotional faces. Notably, though both PRS were
tested for association in a healthy college sample, results were consistent with prior disorderspecific studies. The results of Chapter 2, for instance, are consistent with studies linking
childhood ADHD to future substance use (Charach et al., 2011; S. S. Lee et al., 2011) and a
growing literature tying ADHD, as well as family-based genetic risk for ADHD, to heightened VS
activity to reward receipt (Furukawa et al., 2014; Paloyelis et al., 2012; von Rhein, Cools, Zwiers,
et al., 2015). The results of Chapter 4 are similarly consistent with studies linking DBDs (Alegria
et al., 2016; Noordermeer et al., 2016; Raschle et al., 2015), adult antisocial/criminal behavior
(Arbuckle & Shane, 2016), and psychopathy (Meffert et al., 2013), to blunted social-emotional
insula activity. Though ADHD and CD diagnoses or symptom counts were not available for the
college sample, the association between CD polygenic risk, calculated based on a phenotypically
extreme sample ascertained for opioid dependence, with self-reported psychopathy constructs
among relatively affluent, high-functioning undergraduates indicates that genetic risk for severe
CD pathology also influences non-pathological variation. Therefore, continuous indices of
disorder-related genetic and phenotypic variability can be useful tools in investigating disorder
etiology even within non-clincal samples.
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Additionally, consistent with viewing externalizing psychopathology as existing along a
spectrum encompassing both normal and extreme variation, the results presented here, in particular
those of Chapter 2, provide evidence for a neurogenetic basis for ESD comorbidity and continuity.
It has been hypothesized that the high degree of comorbidity (e.g., 30-50% of children with ADHD
also meet criteria for CD; Biederman et al., 1991) and continuity (e.g., children diagnosed with
ADHD are greater than 2.5-times as likely as nondiagnosed peers to meet criteria for an SUD in
adulthood; Lee et al., 2011) across ESDs is due to differential expression of a continuous latent
externalizing factor across the lifespan. Chapter 2 demonstrated a potential link between two
aspects of externalizing psychopathology, ADHD and problematic alcohol use, wherein both
polygenic risk for ADHD and self-reported problem drinking were associated with heightened VS
activity. Though I could not directly test such a hypothesis in the current data, such results suggest
that genetic risk for ESDs, indexed by ADHD polygenic risk in Chapter 2, may express itself as
ADHD in childhood and then problem drinking in young adulthood, linked neurobiologically
through heightened VS response to reward (see Section 5.1.1 for further discussion).

5.2 Limitations
Though individual study limitations are outlined in detail in each chapter, several limitations are
common to all three studies and should be considered in interpreting findings as a whole. First,
sample sizes were relatively small and likely underpowered to detect effect sizes typically seen in
genetic and imaging studies of complex traits (Bogdan, Hyde, & Hariri, 2013; Poldrack, 2012;
Sullivan et al., 2012). However, oversampling for at-risk individuals in the Teen Alcohol
Outcomes Study (Chapter 3) and Comorbidity and Trauma Study (Chapter 4) boosted cell sizes
and likely enriched for more severe presentations, thus increasing power relative to non81

ascertained samples. Relatedly, the significant effects reported across the studies are unlikely to
be clinically informative on an individual level (e.g., polygenic risk for childhood ADHD in
Chapter 2 explained at most 1.7% of variance in reward-related VS activity). Nonetheless, effects
identified reflect promising biological mechanisms that provide etiologic insight and are worthy
of future study.
Second, despite convergent evidence of association within and across studies (i.e.,
association of CD genetic risk with self-reported psychopathy as well [Chapter 4]; and association
of heightened VS activity to reward with problematic alcohol use [Chapter 2], future initiation of
drinking [Chapter 2], and age-of-first drink [Chapter 3]), I was not able to directly replicate my
largely exploratory findings using the available data. The fields of neuroscience (e.g., Button et
al., 2013), genetics (e.g., Duncan & Keller, 2011), and imaging genetics (e.g., Bogdan et al., 2017),
have faced criticism in recent years for high-profile replication failures, and may be particularly
susceptible to false positives due to the large degree of multiple testing, traditionally small interindividual effect sizes, and methodological flexibility. I attempted to reduce the chance to Type I
error by applying stringent correction in individual analyses (e.g., permutation-based thresholding
in Chapter 2 and GWAS significance and family-wise error correction in Chapter 4); however,
I did not control the error rate across studies and have also reported results not surviving strict
correction, noting as such. These results, and especially those for which no convergent evidence
was presented (e.g., association of GOLM1 with CD), thus should be interpreted cautiously.
Third and finally, despite contextualizing these studies within the framework of the
externalizing spectrum, the available archival data did not permit direct comparisons across
disorders, as only one sample was recruited based on ESD diagnosis (i.e., opioid dependence in
the Comorbidity and Trauma Study, Chapter 4). Chapter 2 is the only study of the three which
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explicitly tests whether a single mechanism may link multiple disorders, and, even then, proxy
measures (i.e., childhood ADHD polygenic risk and self-reported problematic alcohol use) were
used rather than diagnostic criteria. Conversely, it is worth noting that given the high level of other
externalizing behaviors (i.e., Table 4.2) present in the sample in which the conduct disorder
GWAS (Chapter 4) was performed, even among “controls,” it is possible that the genetic risk
identified may be more specific to aggression and antisocial behavior. This is supported by the
association of this genomewide genetic risk with blunted insula response to an emotional facematching task, suggesting that it may be mechanistically related to empathy (Mutschler et al.,
2013). The results of the studies are thus best thought of as complementary, with each providing
insight into one component disorder, behavior, or trait of the externalizing spectrum that may, or
may not, be relevant to other disorders as well.

5.3 Future Directions
The current findings inspire several future research directions that may prove fruitful in identifying
additional mechanisms of ESD risk. Foremost, they highlight the need for additional large-scale
neurogenetic consortia encompassing both pathological and normal/subclinical externalizing
variation. As mentioned in Section 5.2, effects sizes in neurogenetics research are small (Ryan
Bogdan et al., 2017) and require large samples to detect, which are often cost-prohibitive to accrue
at one site. Though I was able to leverage data from three large independent studies—the Duke
Neurogenetics Study in Chapters 2 and 4 (Corral-Frias et al., 2015), Teen Alcohol Outcomes
Study in Chapter 3 (Bogdan et al., 2012), and Comorbidity and Trauma Study in Chapter 4,
(Nelson et al., 2016)—for this project, even larger multimodal samples are needed yet. Consortia
such as the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) network
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(Thompson et al., 2014), Human Connectome Project (Van Essen et al., 2013), UK Biobank
Imaging Study (Miller et al., 2016), Brain Genomics Superstruct Project (Holmes et al., 2015),
and particularly longitudinal studies such as IMAGEN (Schumann et al., 2010) and the Adolescent
Brain Cognitive Development (ABCD) study (Bjork, Straub, Provost, & Neale, 2017), promise to
deliver sample sizes and data coverage that should adequately allow for both a priori and
exploratory analyses of the externalizing spectrum, as well as for adequate cross-study replication.
Furthermore, in keeping with the spirit of National Institute of Mental Health’s Research
Domain Criteria (RDoC; Insel et al., 2010) initiative and the conceptualization of a continuous
spectrum of externalizing psychopathology (Beauchaine & McNulty, 2013), future studies should
focus on quantitative transdiagnostic neural and behavioral phenotypes rather than “discrete”
disorders. As demonstrated, for example, in Chapter 2, certain intermediate phenotypes such as
heightened reward-related VS activity may be related to multiple externalizing disorders,
especially when disorders exhibit high comorbidity and/or continuity. Conversely, within-disorder
heterogeneity, as in, for instance, conduct disorder with and without the DSM-5 “with limited
prosocial emotions” specifier, may obscure key subtype-specific neural and genetic differences
when using only a case-control diagnostic design. As mentioned in Sections 5.1.1 and 5.2, I was
unable to establish disorder specificity vs. generality for the candidate genetically influenced
neural mechanisms (i.e., heightened reward-related VS activity and blunted anterior insula activity
during social-emotional processing) I identified. Perhaps a more useful future follow-up, instead
of testing disorder specificity, would be to test which continuous externalizing traits (e.g.,
impulsivity, aggression, and [lack of] empathy) do and do not associate with such neural activity.
Finally, though genetic correlation methods such as polygenic risk scores, as used in
Chapters 2 and 4, are useful in determining whether neural phenotypes are associated with whole84

genome risk for certain disorders, they do not allow for the identification of specific regions,
systems, or pathways within the genome underlying such links. For example, it is unlikely that
every childhood ADHD risk locus also contributes to heightened reward-related VS activity, as
the PRS method assumes; instead, likely a subset, perhaps those coding for proteins in the
dopaminergic system (e.g., as in Nikolova, Ferrell, Manuck, & Hariri, 2011), influences both.
Newer statistical genetics methods have allowed for the partitioning of heritability (Finucane et
al., 2015) and co-heritability (Shi, Mancuso, Spendlove, & Pasaniuc, 2016), such that areas of the
genome exerting disproportionate influence on one or two correlated phenotypes may be
identified. Additionally, weights from prior GWAS may be combined with a priori knowledge of
likely related pathways to form pathway-specific PRS (Darst et al., 2017). Future use of such
techniques will provide more insight into specific molecular pathways linking genes to brain to
behavior, further refining targets for treatment.

5.4 Conclusion
In three complementary studies, I have identified promising genetic markers and genetically
influenced functional neural phenotypes (i.e., reward-related ventral striatum and socialemotional anterior insula activation) for externalizing psychopathology and related traits. I have
additionally provided evidence that they represent premorbid risk factors, rather than disorder- or
substance-related effects, linked to normal trait variation in the population. Despite several
notable limitations, including relative lack of power, need for direct replication, and inability to
compare across disorders, these findings lay the groundwork for future neurogenetic reseach into
general and specific risk mechanisms for externalizing pathology which may eventually lead to
improved treatment and prevention strategies in halting potentially lifelong impairment.
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Appendix A:
Chapter 3 Supplemental Analyses
Though I had originally planned to investigate predictive neural markers of alcohol use escalation,
as well as downstream neural consequences of use, among individuals who initiated drinking
during the course the Teen Alcohol Outcomes Study (TAOS; Bogdan, Williamson, & Hariri,
2012), restricted variability in drinking behavior prohibited an adequate treatment of these
hypotheses in the main document. As such, I limited Chapter 3 to addressing alcohol use initiation
in the form of early vs. late age-of-first-drink, for which sufficient variability was present in TAOS.
However, I have summarized below the analyses I performed in assessing the current state of the
drinking and longitudinal reward-related neuroimaging data in TAOS, in the hopes of inspiring
additional discussion and adequate follow-up. Notably, a third wave of imaging data is currently
being collected in the sample, and the results of these preliminary analyses may be used to inform
future analyses related to neural predictors and consequences of alcohol use escalation and
problem drinking.

A.1 Alcohol Use Escalation in TAOS
In an attempt to index alcohol use escalation among individuals who initiated use during the study
(n=66 with usable baseline imaging data), I created three variables based on responses to the
Substance Use Questionnaire (SUQ; Molina et al., 2007): slope of use across timepoints, lastmonth use among first-time drinkers, and time-to-first-drunkenness (Figure A.1). However, due
to lack of variation in these measures, further analyses were not pursued. The process of creating
and evaluating these variables is described below.
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Figure A.1 Variables Developed to Index Alcohol Use Escalation. Panels correspond to A) Slope of Use, B) Lastmonth Use Among First-time Drinkers, and C) Time-to-first-drunkenness.

A.1.1 Escalation Variables
Slope of Use
As indicated in my proposal, to develop a “slope of use” metric, I first multiplied frequency-ofuse (i.e., response to the SUQ question “In the past 12 months, how often did you drink beer, wine,
wine coolers, or liquor?”, where answers among past-year drinkers may range from “1-3 times” to
“Several times a day”) and quantity-of-use (i.e., response to the SUQ question “Think of all the
[113]

times you have had a drink in the past 12 months. How much did you usually drink each time?”,
where answers among past-year drinkers may range from “Less than one can or glass” to “More
than 25 drinks”) data to create an overall “use score,” as done previously by Ramage and
colleagues (Ramage, Lin, Olvera, Fox, & Williamson, 2015), at each of the six assessment
timepoints (i.e., baseline and five follow-up). I had then planned to enter these scores into a latent
growth model, with the individual slopes from the resultant model representing the rapidness of
alcohol use escalation across timepoints for each participant. However, given that most individuals
with baseline imaging data who initiated drinking during the study did so at later timepoints
(M=3.95±1.21), visual inspection of the data revealed patterns to be nonlinear (Figure A.1).
Therefore, the slopes were not actually representative of rapidness of escalation in a linear fashion;
instead, they were heavily influenced by timepoint-at-first-drink and thus were not appropriate for
main analyses in Chapter 3.
Last-month Use Among First-time Drinkers
As an alternative to the use of slope to index rapidness of alcohol use escalation, I instead tried
using self-reported last-month alcohol use at the timepoint at which an individual first reported
drinking. For example, if an individual reported first drinking at timepoint 3 (i.e., “Did you have
your very first drink since your last interview here?”), his or her past-month alcohol use frequency
(i.e., “Think specifically about the past 30 days up to today. During the past 30 days, what is your
best estimate of the number of days you drank one or more drinks of an alcoholic beverage?",
where answers among past-year drinkers may range from “0 days” to “All 30 days”) would be
multiplied by his or her past-month alcohol use quantity (i.e., “On the days that you drank during
the past 30 days, how many drinks did you usually have each day? Count as a drink a can or bottle
of beer, a wine cooler or a glass of wine, champagne or sherry; a shot of liquor or a mixed drink
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or cocktail.”) to create a metric of past-month number of drinks among first-time drinkers. Lastmonth, rather than last-year, number of drinks was selected to reduce potential bias introduced by
individuals having begun to drink within only months of the interview, rather than during the entire
12-month period the past-year questions inquire about. However, not much inter-individual
variation was captured by this measure (M=2.03±2.76), with most first-time drinkers reporting
only 1-2 or fewer drinks in the past month (Figure A.1.B). As such, further analyses were not
pursued.
Time-to-first-drunkenness
Finally, hoping to index rapidness of escalation to problematic drinking specifically, I calculated
“time-to-first-drunkenness” by subtracting self-reported age-at-first-drunkenness (i.e., “How old
were you when you first got drunk or very, very high on alcohol?”) from age-at-first-drink (i.e.,
“How old were you the first time you had a drink, not just a sip or a taste?”). Of the 66 alcohol use
initiators included in my imaging subsample, only 39 reported having also gotten drunk during the
course of the study. Consistent with prior literature (Monshouwer, Smit, de Zwart, Spruit, & van
Ameijden, 2003; Morean, Corbin, & Fromme, 2012), participants reported a short period from
first drink to first drunkenness, with the majority of those who reported getting drunk doing so
within the first year of initiating alcohol use (n=26). Due to lack of variation in this measure
(M=0.58±0.87), it was not deemed appropriate for main analyses (Figure A.1.C).

A.1.2 Interim Conclusions
As perhaps should have been expected in a sample of participants first interviewed in early
adolescence, individual differences in problem drinking behaviors were insufficient to warrant
further analyses for the current project (Figure A.1); initiation was the primary stage of alcohol
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use captured within this sample, as became my focus in Chapter 3. One potentially more fruitful
avenue of research, currently being pursued by our collaborators at Duke University, may be to
characterize the shape of alcohol use trajectories, rather than assuming a linear trajectory and
modelling slope. Despite a common overall developmental pattern of alcohol use initiation,
escalation, and progression to problem drinking during adolescence (Chassin, Sher, Hussong, &
Curran, 2013; Johnston, 2016; Substance Abuse and Mental Health Services Administration,
2015), past studies using latent class growth analysis (LCGA) and growth mixture modelling
(GMM) have identified multiple discrete adolescent alcohol use trajectories, including stable
low/no use, swift escalation to chronic high levels of drinking, and more gradual escalation (see
Table 1 in Nelson, Van Ryzin, & Dishion, 2015, for review), and found individuals belonging to
certain trajectories (e.g., rapid escalation) to be particularly susceptible to future addiction (Colder,
Campbell, Ruel, Richardson, & Flay, 2002; Nelson et al., 2015). Notably, such an analysis
addresses a fundamentally different question than does looking at initiation and escalation
independently; however, in the absence of substantial individual differences in drinking behavior,
it may be the only way to capture variation beyond initiation in adolescent samples.

A.2 Whole-brain Main Effects of Task
Though I decided to focus exclusively on one a priori region of interest, the ventral striatum, in
Chapter 3, I also probed whole-brain activation to the monetarily incentivized number-guessing
paradigm (Delgado, Nystrom, Fissell, Noll, & Fiez, 2000; Hariri et al., 2006) as part of this project.
Notably, these analyses were not limited to baseline nondrinkers, as I was interested in overall
main effects.
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A.2.1 Methods
As described in Section 3.2.3, following preprocessing steps, the general linear model in Statistical
Parametric Mapping 8 (SPM8; http://www.fil.ion.ucl.ac.uk/spm), employing canonical
hemodynamic response functions, was used to estimate condition-specific (i.e., positive feedback,
negative feedback, and control block) BOLD responses for each individual with usable imaging
data (see Section 3.2.3 for a description of imaging QC) at each scanning session (NMRI1=214;
NMRI2=193; NMRI1&MRI2=131).
Main Effects at Each Scanning Session
As outlined in SPM8’s random-effects analysis via summary statistics approach (Holmes &
Friston, 1998; Penny, Holmes, & Friston, 2003), Positive Feedback > Negative Feedback contrast
images (i.e., weighted sums of single-condition beta images) for each individual were used in
second-level random effects models to determine mean contrast-specific responses at each
scanning session (NMRI1=214; NMRI2=193) using one-sample t-tests.
Common Areas of Activation Across Sessions
A 2 session (scan 1, scan 2) x 2 condition (positive, negative) repeated-measures ANOVA with an
explicitly modeled subject-level factor, implemented using SPM8’s flexible factorial option
(Henson & Penny, 2003), was used to model common areas of activation across participants with
usable imaging data at both sessions (NMRI1&MRI2=131). Following model estimation, weights were
assigned to the resulting whole-brain beta maps based on the recommendations of Gläscher and
Gitelman (2008) to assess the main effect of condition (i.e., Positive Feedback > Negative
Feedback) across both sessions.
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Differences in Activation Across Sessions
To investigate systematic changes in activation across sessions, Positive Feedback > Negative
Feedback contrast images for each session for each participant with usable imaging data at both
scans (NMRI1&MRI2=131) were entered into a paired samples t-test in SPM8.
Significance Assessment
Cluster-level significance was assessed at α=0.05 using AFNI’s 3dClustSim (Cox, 1996), as
described in Section 3.2.4. The results of these simulations indicated that cluster sizes of 102
voxels for the session-specific analyses, 96 for the ANOVA, and 91 for the paired t-test at a pthreshold of p<0.001 would appropriately control the cluster-level family-wise error rate.

A.2.2 Results
Main Effects at Each Scanning Session
Across both scanning sessions, the contrast of positive feedback versus negative feedback elicited
robust activation in the striatum (Figure A.2). At session 1, the only significant cluster (k [or
cluster size]=125, p<0.05 FWE; max voxel MNI coordinates=[-4, 8, -6], t=4.38, ns FWE; Figure
A.2A) encompassed the left ventral striatum (i.e., ventral portions of the caudate and putamen as
well as the olfactory tubercle). At session 2, a larger, more lateral cluster emerged within the left
striatum (k=206, p<0.005 FWE; max voxel=[-14, 0, -10], t=4.85, ns FWE; Figure A.2B), situated
primarily within the lentiform nucleus (i.e., putamen and globus pallidus) but also extending into
the ventral striatum (i.e., ventral putamen).
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Figure A.2 Whole-brain Main-effect-of-task Analyses. Panels correspond to mean group-level Positive Feedback
> Negative Feedback contrast A) at scanning session 1, B) at scanning session 2, and C) across both sessions. All
images are displayed at the coordinates of the maximum voxel, with the exception of the midline image in order to
highlight both significant clusters. All clusters displayed meet an FWE-corrected threshold of p<0.05.
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Common Areas of Activation Across Sessions
In the repeated-measures ANOVA, modelling both sessions simultaneously, a common region of
activation within the ventral striatum was revealed (k=113, p<0.05 FWE; max voxel=[-14, 10, 10], t=4.64, ns FWE; Figure A.2C). Additionally, clusters along the midline within the cingulate
gyrus (k=272, p<0.005 FWE; max voxel=[-2, 2, 24], t=4.68, ns FWE) and cerebellum (k=111,
p<0.05 FWE; max voxel = [0, -72, -12], t=3.72, ns FWE) were differentially activated to positive
versus negative feedback across sessions.
Differences in Activation Across Sessions
No regions systematically differed in activation across sessions for the contrast of Positive
Feedback > Negative Feedback, per the results of the paired t-test. Restricted analyses with
bilateral prior-coordinate-based ventral striatum (i.e., based on maximum coordinates from Hariri
et al., 2006) and dorsal striatum anatomical (i.e., bilateral caudate and putamen; Tzourio-Mazoyer
et al., 2002) regions-of-interest (ROIs) also did not yield any differences in activation across the
two sessions.

A.2.3 Interim Conclusions
Consistent with prior studies using this corticostriatal reactivity paradigm (Delgado et al., 2000;
Hariri et al., 2006; Chapter 2), the Positive Feedback > Negative Feedback contrast revealed
consistent activation differences within the left ventral striatum across participants and scanning
sessions, indicating that such differences are present even in early and middle adolescence.
Correspondingly, no significant effects of scanning session were found at either the whole-brain
level or within a priori striatum ROIs, providing evidence that there is no systematic change in
activation over time, at least in the TAOS sample, from early to middle adolescence. Visual
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inspection of the statistical maps, however, suggested that there might be a shift in activation from
medial to lateral areas of the striatum as adolescence progresses. Though its potential functional
significance is at the moment unclear, it is worth noting that prior studies have suggested a
ventromedial-dorsolateral, rather than purely dorsal and ventral, division of the striatum based on
cytoarchitecture and patterns of connectivity (Burton, Nakamura, & Roesch, 2015; Voorn,
Vanderschuren, Groenewegen, Robbins, & Pennartz, 2004), and that, using traditional dorsalventral divisions, functional connectivity between the dorsal and ventral striatum is strengthened
in adolescence relative to both childhood and adulthood (Somerville, Hare, & Casey, 2011). As
such, the “seat” of reward processing, in terms of both function and connectivity, may shift during
the critical developmental period of adolescence. However, this impression is highly speculative
and should be the subject of more rigorous future evaluation.

A.3 Longitudinal Effects of Initiation and Escalation
To shed light on the role of reward processing in different stages of substance use and addiction
(Everitt & Robbins, 2016; Hommer, Bjork, & Gilman, 2011; Koob, 2013; Koob & Le Moal, 2005;
Volkow, Fowler, Wang, Baler, & Telang, 2009; Wise & Koob, 2014), as well as reconcile previous
discrepant findings on the directionality of the association between reward-related ventral striatum
activity and drinking (Balodis & Potenza, 2015; Heitzeg et al., 2014; Hommer et al., 2011; Stice,
Yokum, & Burger, 2013; Weiland, Zucker, Zubieta, & Heitzeg, 2016; Chapter 2), I utilized the
longitudinal neuroimaging data within the TAOS sample to look at downstream consequences of
alcohol use initiation and escalation. Due to my shift of focus within Chapter 3 to prospective
predictors of age-at-first-drink, I have decided to present the preliminary results of these analyses
below.
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A.3.1 Initiation and Escalation Groups
As reported in Section A.2.1, following exclusions for imaging quality issues, 131 participants
had usable imaging data at both scanning sessions.
Initiation
Of these participants, 9 reported drinking at baseline and were thus excluded from longitudinal
initiation analyses. By the second scanning session, 23 reported having initiated drinking, with 98
remaining abstinent, and one failing to report drinking status at the second scan.
Table A.1 Longitudinal Initiation Subsample Demographics
Variable
N
Age at Scan 1
Age at Scan 2
Years between Scans
Tanner Stage >III at Baseline
Female
Non-Hispanic Caucasian
Hispanic

Abstainer
98
13.48(0.94)
15.51(0.98)
2.03(0.33)
54.1%
46.9%
63.3%
19.4%

Initiator
23
13.87(0.89)
16.14(0.92)*
2.27(0.50)*
56.5%
30.4%
65.2%
34.8%

*Indicates a significant difference between groups.

“Escalation”
As discussed in Section A.1, there was little variation in post-initiation drinking behavior within
TAOS. Additionally, there were only 9 individuals in the sample who reported drinking by the
time of the first scan, so a longitudinal assessment of neural correlates of escalation post-initiation
was not feasible. Instead, I decided to compare participants who reported binge drinking (n=8) to
drinkers who did not report binge drinking (n=20) at scanning session 2, regardless of baseline
drinking status. Binge drinking status was determined based on NIAAA criteria (i.e., 4+ drinks for
females, and 5+ drinks for males, within a two-hour period; National Institute on Alcohol Abuse
and Alcoholism), by binarizing responses to the following questions on the SUQ: “In the past 12
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months, how often did you drink four or more drinks within about two hours?” and “In the past 12
months, how often did you drink five or more drinks within about two hours?”
Table A.2 Longitudinal Binge-drinking Subsample Demographics
Variable
N
Age at Scan 1
Age at Scan 2
Years between Scans
Tanner Stage >III+ at Baseline
Female
Non-Hispanic Caucasian
Hispanic

Non-binging Drinker
20
13.89(0.93)
16.13(0.96)
2.24(0.50)
60.0%
40.0%
65.0%
30.0%

Binge Drinker
8
14.02(0.68)
16.31(0.71)
2.29(0.46)
62.5%
62.5%
62.5%
37.5%

Note. No significant differences in demographics between groups.

A.3.2 Ventral Striatum
Methods
To index change in ventral striatum activity across timepoints, parameter estimates were extracted
for the Positive Feedback > Negative Feedback contrast at each session from the maximum voxel
(i.e., MNI coordinates=[-14, 10, -10], t=4.64) of the left VS cluster identified in the 2 session x 2
condition repeated-measures ANOVA described in Section A.2. Change scores across sessions
were then generated for each participant by conducting a linear regression with scan 1 parameter
estimates as the independent variable and scan 2 estimates as the dependent variable. Residuals
from this model thus represented deviation from expected scan 2 VS activity as predicted by
baseline activity. For example, a positive residual value would reflect a greater increase in activity
over time relative to that expected. This approach has been previously utilized in longitudinal
imaging analyses (e.g., Whittle et al., 2014), including within the TAOS dataset (Hanson, Hariri,
& Williamson, 2015). Change scores were then entered into logistic regressions predicting
initiation or binge drinking status, respectively. Covariates for all analyses included age and
pubertal status at baseline, gender, race/ethnicity, and days from scan 1 to 2.
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Results
Change in left reward-related VS activity over time was nominally associated with binge drinking
(β=-1.005, p=0.039; Figure A.3), but not initiation status, at session 2 (β=-0.185, p=0.454). For
each standard-deviation decrease in left VS activity relative to that expected, odds of belonging to
the binge-drinking group increased by a factor of 2.732.

Figure A.3 Longitudinal VS Activity and Binge Drinking. Average trajectories for each group are shown in bold,
with error bars representing standard error of the mean at each session. Individual trajectories, colored by group
membership, are shown in the background. No significant differences emerged between the groups at individual
scanning sessions.

A.3.3 Whole-brain
Methods
Two-group (abstainer vs. initiator in the first analysis, and binge drinker vs. non-binge drinker in
the second) x 2 time (scan1 , scan 2) repeated-measures ANCOVAs with explicitly modeled
subject-level factors, implemented using SPM8’s flexible factorial option (Henson & Penny,
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2003), were used to test for longitudinal differences in whole-brain activation to the Positive
Feedback > Negative Feedback contrast. Covariates included age at each scan, pubertal status at
baseline, gender, and race/ethnicity. Following model estimation, weights were assigned to the
resulting whole-brain beta maps to test for group x time interactions. Cluster-level significance
was assessed as described in Section 3.2.4, which resulted in minimum cluster size thresholds of
92 and 104 voxels, for initiation and binge-drinking analyses, respectively, at p<0.001. In addition
to probing whole-brain activation, I also performed analyses within bilateral prior-coordinatebased ventral striatum (i.e., based on maximum coordinates from Hariri et al., 2006) and dorsal
striatum anatomical (i.e., bilateral caudate and putamen; Tzourio-Mazoyer et al., 2002) ROIs.
Results
No significant regions of activation emerged at the whole-brain or ROI-level for either model,
FWE-corrected. However, inspection of the statistical map for the group x time interaction in the
initiation analysis at the cluster-forming threshold of p<0.001, uncorrected, revealed three clusters
within the prefrontal cortex (PFC) separated by white matter. As activation can sometimes be
present outside of grey matter due to the imprecision of BOLD fMRI, as well as spatial smoothing
procedures, I reexamined the statistical map at p<0.001 without using the probabilistic grey matter
mask. As I had suspected, the original PFC clusters were now joined, and the full cluster survived
FWE correction (revised k=102 at p<0.001; PFC k=107, p<0.05 FWE; max voxel=[-16, 48, 10],
t=3.84, ns FWE; Figure A.4.A).
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Figure A.4 Longitudinal PFC Activity and Alcohol Use Initiation. Shown in A is the significant cluster that
emerged from the Group x Scan interaction of the alcohol use initiation ANCOVA, centered at the maximum voxel:
[-16, 48, 10]. As can be seen in the visualization of the extracted values in B, future alcohol use initiators had less
activation at baseline relative to abstainers, but by scan 2 the groups were statistically equivalent.
*p<0.05, +p<0.10

Follow-up independent samples t-tests using extracted parameter estimates averaged across the
entire cluster revealed that at scan 1, future initiators had significantly decreased activation within
the cluster relative to continuous abstainers (t(25)=-2.255, p=0.033), but that at the time of scan 2,
the two groups were statistically equivalent (t(25)=1.760, p=0.091), with a nonsignificant trend
towards greater activation among initiators.

A.3.4 Interim Conclusions
Though preliminary at this point, results of longitudinal analyses suggest that alcohol use initiation
is associated with an increase in reward-related (vm)PFC activity over time, while initiation of
binge drinking specifically is associated with a relative decrease in VS activity. The latter finding
is consistent with stage models of addiction, which posit that heightened reward sensitivity
underlies initial stages of addiction such as initiation and escalation, but that later stages including
progression to and maintenance of dependence may be driven by a revised reward-system
homeostasis in which the substance itself replaces natural, non-substance rewards (Everitt &
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Robbins, 2016; Hommer et al., 2011; Koob, 2013; Koob & Le Moal, 2005; Volkow et al., 2009;
Wise & Koob, 2014). Such a role for chronic use of alcohol and other substances in repressing
reward responsiveness has been documented in fMRI (Balodis & Potenza, 2015; Hommer et al.,
2011) and PET (Volkow et al., 2009; Volkow, Fowler, Wang, & Swanson, 2004) studies of
humans, as well as in animal models (Ahmed, Kenny, Koob, & Markou, 2002; Budygin et al.,
2007; Zhou et al., 2007). Though binge drinking cannot be directly compared to dependence, it
represents a problematic pattern of hazardous alcohol use, particularly during the sensitive
developmental period of adolescence. If the association between heightened VS activity and
prospective prediction of alcohol use initiation, but longitudinal association between decreasing
VS activity over time among binge-drinkers, is replicated in additional larger samples, it could
present a key piece of evidence for the role of reward processing in the progression through stages
of addiction.
The association between alcohol use initiation and increasing reward-related PFC activity
over time, particularly within the vmPFC, where the maximum voxel was located, was admittedly
unexpected. However, the PFC in general, and vmPFC in particular, has been previously
associated with reward processing and undergoes significant development during adolescence (see
Casey & Jones, 2010, for a developmental review). Notably, only two other studies to date, at least
to my knowledge, have examined neural activation both pre- and post-initiation of alcohol use
(Squeglia et al., 2012; Wetherill, Squeglia, Yang, & Tapert, 2013); in them, the authors reported
similar crossover effects within the right inferior parietal lobe and left medial frontal cortex during
a working memory task, and right middle frontal gyrus and inferior parietal lobule during a
response inhibition task, respectively, wherein future heavy drinkers had lesser activation than
continuous nondrinkers at scan 1, but by scan 2 their relative activation in these regions increased,
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while that of continuous nondrinkers decreased. Given that so little research has been previously
conducted regarding neural activity pre- and post- alcohol use initiation, the current preliminary
finding is worthy of further follow-up both within this sample, especially as data from the third
neuroimaging session becomes available, and in additional longitudinal samples.

A.4 Lessons Learned and Looking Forward
Overall, my work with alcohol use and longitudinal imaging data in the TAOS dataset has
produced interesting preliminary results regarding the role of heightened reward-related VS
activity in predicting age-at-first drink (Chapter 3), as well as potential effects of initiation and
binge drinking on activity within the PFC and VS (A.3), respectively. Additionally, it has
identified specific methodological issues when working with substance use and imaging data
within an adolescent population, including lack of variability in post-initiation drinking behaviors
(A.1) and lack of adequate characterization of the developmental timecourse of activation to
functional imaging tasks previously used and validated primarily in adults (A.2). The “grunt” work
involved in such initial analyses often does not make it into final manuscripts or the main chapters
of dissertations such as this one; nonetheless, as discussed in the individual conclusions to each
subsection, they provide valuable information relevant to the design of future studies as well as
future analyses. As additional longitudinal data become available, both in the TAOS sample and
large-scale collaborations such as the Adolescent Brain and Cognitive Development project, which
seeks to provide detailed longitudinal neuroimaging, genetic, and phenotypic data on 10,000 9- to
10-year-olds as they progress through adolescence and young adulthood (Bjork, Straub, Provost,
& Neale, 2017), a more thorough treatment of questions regarding predictors and consequences of
alcohol use initiation and escalation will become feasible.
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